CONSOLIDATED SCHEDULE OF INVESTMENTS £ in Thousands, $ in Thousands |
9 Months Ended |
12 Months Ended |
|
|
Sep. 30, 2023
USD ($)
shares
|
Dec. 31, 2022
USD ($)
shares
|
Sep. 30, 2023
GBP (£)
shares
|
Dec. 31, 2022
GBP (£)
shares
|
Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
|
Investment, basis spread, variable rate |
|
8.50%
|
|
7.50%
|
|
8.50%
|
|
7.50%
|
|
Investment cost |
|
$ 3,308,894
|
|
$ 3,005,696
|
|
|
|
|
|
Investments at Fair Value |
|
3,261,391
|
|
$ 2,963,955
|
|
|
|
|
|
Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and AmplifyBio, LLC, Warrant, Acquisition Date 12/27/2022, Class A Units |
|
|
|
|
|
|
|
|
|
Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[1],[2] |
238
|
|
|
|
|
|
|
|
Investments at Fair Value |
[1] |
$ 172
|
|
|
|
|
|
|
|
Shares | shares |
[1] |
69,239
|
|
|
|
69,239
|
|
|
|
Investments Owned Acquisition Date |
[1],[3] |
Dec. 27, 2022
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments (187.15%) |
|
|
|
|
|
|
|
|
|
Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
|
Investment owned, percent of net assets |
[4] |
187.15%
|
|
|
|
187.15%
|
|
|
|
Investment cost |
[2] |
$ 3,131,673
|
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 3,091,880
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments (199.47%) |
|
|
|
|
|
|
|
|
|
Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
|
Investment owned, percent of net assets |
[5] |
|
|
199.47%
|
|
|
|
199.47%
|
|
Investment cost |
[6] |
|
|
$ 2,818,060
|
|
|
|
|
|
Investments at Fair Value |
|
|
|
$ 2,795,444
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Biotechnology Tools (2.02%) |
|
|
|
|
|
|
|
|
|
Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
|
Investment owned, percent of net assets |
[4] |
2.02%
|
|
|
|
2.02%
|
|
|
|
Investment cost |
[2] |
$ 32,927
|
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 33,449
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Biotechnology Tools (2.31%) |
|
|
|
|
|
|
|
|
|
Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
|
Investment owned, percent of net assets |
[5] |
|
|
2.31%
|
|
|
|
2.31%
|
|
Investment cost |
[6] |
|
|
$ 32,339
|
|
|
|
|
|
Investments at Fair Value |
|
|
|
$ 32,339
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Biotechnology Tools and Alamar Biosciences, Inc. Senior Secured, Maturity Date June 2026, Prime + 3.00%, Floor rate 6.50%, PIK Interest 1.00%, 5.95% Exit Fee |
|
|
|
|
|
|
|
|
|
Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2026-06
|
[7],[8],[9] |
2026-06
|
[10] |
2026-06
|
[7],[8],[9] |
2026-06
|
[10] |
Investment, basis spread, variable rate |
|
3.00%
|
[7],[8],[9],[11] |
3.00%
|
[10],[12] |
3.00%
|
[7],[8],[9],[11] |
3.00%
|
[10],[12] |
Investment, interest rate, floor |
|
6.50%
|
[7],[8],[9],[11] |
6.50%
|
[10],[12] |
6.50%
|
[7],[8],[9],[11] |
6.50%
|
[10],[12] |
Investment, interest rate, paid in kind |
|
1.00%
|
[7],[8],[9],[11] |
1.00%
|
[10],[12] |
1.00%
|
[7],[8],[9],[11] |
1.00%
|
[10],[12] |
Principal amount |
|
$ 5,036
|
[7],[8],[9] |
$ 5,000
|
[10] |
|
|
|
|
Investment cost |
|
5,069
|
[2],[7],[8],[9] |
4,951
|
[6],[10] |
|
|
|
|
Investments at Fair Value |
|
$ 5,135
|
[7],[8],[9] |
$ 4,951
|
[10] |
|
|
|
|
Investment exit fee |
|
5.95%
|
[7],[8],[9],[11] |
5.95%
|
[10],[12] |
5.95%
|
[7],[8],[9],[11] |
5.95%
|
[10],[12] |
Investment, Identifier [Axis]: Debt Investments Biotechnology Tools and PathAI, Inc., Senior Secured, Maturity Date January 2027, Prime + 2.15%, Floor rate 9.15%, 11.21% Exit Fee |
|
|
|
|
|
|
|
|
|
Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2027-01
|
[9],[13] |
2027-01
|
[10] |
2027-01
|
[9],[13] |
2027-01
|
[10] |
Investment, basis spread, variable rate |
|
2.15%
|
[9],[11],[13] |
2.15%
|
[10],[12] |
2.15%
|
[9],[11],[13] |
2.15%
|
[10],[12] |
Investment, interest rate, floor |
|
9.15%
|
[9],[11],[13] |
9.15%
|
[10],[12] |
9.15%
|
[9],[11],[13] |
9.15%
|
[10],[12] |
Principal amount |
|
$ 28,000
|
[9],[13] |
$ 28,000
|
[10] |
|
|
|
|
Investment cost |
|
27,858
|
[2],[9],[13] |
27,388
|
[6],[10] |
|
|
|
|
Investments at Fair Value |
|
$ 28,314
|
[9],[13] |
$ 27,388
|
[10] |
|
|
|
|
Investment exit fee |
|
11.21%
|
[9],[11],[13] |
11.21%
|
[10],[12] |
11.21%
|
[9],[11],[13] |
11.21%
|
[10],[12] |
Investment, Identifier [Axis]: Debt Investments Communications & Networking (6.41%) |
|
|
|
|
|
|
|
|
|
Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
|
Investment owned, percent of net assets |
[4] |
6.41%
|
|
|
|
6.41%
|
|
|
|
Investment cost |
[2] |
$ 105,393
|
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 105,952
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Communications & Networking (7.26%) |
|
|
|
|
|
|
|
|
|
Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
|
Investment owned, percent of net assets |
[5] |
|
|
7.26%
|
|
|
|
7.26%
|
|
Investment cost |
[6] |
|
|
$ 99,167
|
|
|
|
|
|
Investments at Fair Value |
|
|
|
$ 101,734
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Communications & Networking and Aryaka Networks, Inc. Senior Secured, Maturity Date July 2026, Prime + 3.25%, Floor rate 6.75%, PIK Interest 1.05%, 3.55% Exit Fee |
|
|
|
|
|
|
|
|
|
Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2026-07
|
[7],[9],[13],[14] |
2026-07
|
[10],[15],[16] |
2026-07
|
[7],[9],[13],[14] |
2026-07
|
[10],[15],[16] |
Investment, basis spread, variable rate |
|
3.25%
|
[7],[9],[11],[13],[14] |
3.25%
|
[10],[12],[15],[16] |
3.25%
|
[7],[9],[11],[13],[14] |
3.25%
|
[10],[12],[15],[16] |
Investment, interest rate, floor |
|
6.75%
|
[7],[9],[11],[13],[14] |
6.75%
|
[10],[12],[15],[16] |
6.75%
|
[7],[9],[11],[13],[14] |
6.75%
|
[10],[12],[15],[16] |
Investment, interest rate, paid in kind |
|
1.05%
|
[7],[9],[11],[13],[14] |
1.05%
|
[10],[12],[15],[16] |
1.05%
|
[7],[9],[11],[13],[14] |
1.05%
|
[10],[12],[15],[16] |
Principal amount |
|
$ 15,113
|
[7],[9],[13],[14] |
$ 5,023
|
[10],[15],[16] |
|
|
|
|
Investment cost |
|
15,009
|
[2],[7],[9],[13],[14] |
4,969
|
[6],[10],[15],[16] |
|
|
|
|
Investments at Fair Value |
|
$ 15,536
|
[7],[9],[13],[14] |
$ 5,053
|
[10],[15],[16] |
|
|
|
|
Investment exit fee |
|
3.55%
|
[7],[9],[11],[13],[14] |
3.55%
|
[10],[12],[15],[16] |
3.55%
|
[7],[9],[11],[13],[14] |
3.55%
|
[10],[12],[15],[16] |
Investment, Identifier [Axis]: Debt Investments Communications & Networking and Cytracom Holdings LLC Senior Secured, Maturity Date February 2025, 3-month LIBOR + 9.31%, Floor rate 10.31% |
|
|
|
|
|
|
|
|
|
Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[10],[17],[18] |
|
|
2025-02
|
|
|
|
2025-02
|
|
Investment, basis spread, variable rate |
[10],[12],[17],[18] |
|
|
9.31%
|
|
|
|
9.31%
|
|
Investment, interest rate, floor |
[10],[12],[17],[18] |
|
|
10.31%
|
|
|
|
10.31%
|
|
Principal amount |
[10],[17],[18] |
|
|
$ 8,910
|
|
|
|
|
|
Investment cost |
[6],[10],[17],[18] |
|
|
8,768
|
|
|
|
|
|
Investments at Fair Value |
[10],[17],[18] |
|
|
$ 8,748
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Communications & Networking and Cytracom Holdings LLC Senior Secured, Maturity Date February 2025, 3-month SOFR + 9.72%, Floor rate 10.62% |
|
|
|
|
|
|
|
|
|
Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[9],[19],[20] |
2025-02
|
|
|
|
2025-02
|
|
|
|
Investment, basis spread, variable rate |
[9],[11],[19],[20] |
9.72%
|
|
|
|
9.72%
|
|
|
|
Investment, interest rate, floor |
[9],[11],[19],[20] |
10.62%
|
|
|
|
10.62%
|
|
|
|
Principal amount |
[9],[19],[20] |
$ 3,275
|
|
|
|
|
|
|
|
Investment cost |
[2],[9],[19],[20] |
3,242
|
|
|
|
|
|
|
|
Investments at Fair Value |
[9],[19],[20] |
$ 3,274
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Communications & Networking and Rocket Lab Global Services, LLC Senior Secured, Maturity Date June 2024, Prime + 4.90%, Floor rate 8.15%, PIK Interest 1.25%, 3.25% Exit Fee |
|
|
|
|
|
|
|
|
|
Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2024-06
|
[7],[8],[13],[19],[21] |
2024-06
|
[16],[17],[22],[23],[24] |
2024-06
|
[7],[8],[13],[19],[21] |
2024-06
|
[16],[17],[22],[23],[24] |
Investment, basis spread, variable rate |
|
4.90%
|
[7],[8],[11],[13],[19],[21] |
4.90%
|
[12],[16],[17],[22],[23],[24] |
4.90%
|
[7],[8],[11],[13],[19],[21] |
4.90%
|
[12],[16],[17],[22],[23],[24] |
Investment, interest rate, floor |
|
8.15%
|
[7],[8],[11],[13],[19],[21] |
8.15%
|
[12],[16],[17],[22],[23],[24] |
8.15%
|
[7],[8],[11],[13],[19],[21] |
8.15%
|
[12],[16],[17],[22],[23],[24] |
Investment, interest rate, paid in kind |
|
1.25%
|
[7],[8],[11],[13],[19],[21] |
1.25%
|
[12],[16],[17],[22],[23],[24] |
1.25%
|
[7],[8],[11],[13],[19],[21] |
1.25%
|
[12],[16],[17],[22],[23],[24] |
Principal amount |
|
$ 85,375
|
[7],[8],[13],[19],[21] |
$ 84,581
|
[16],[17],[22],[23],[24] |
|
|
|
|
Investment cost |
|
87,142
|
[2],[7],[8],[13],[19],[21] |
85,430
|
[6],[16],[17],[22],[23],[24] |
|
|
|
|
Investments at Fair Value |
|
$ 87,142
|
[7],[8],[13],[19],[21] |
$ 87,933
|
[16],[17],[22],[23],[24] |
|
|
|
|
Investment exit fee |
|
3.25%
|
[7],[8],[11],[13],[19],[21] |
3.25%
|
[12],[16],[17],[22],[23],[24] |
3.25%
|
[7],[8],[11],[13],[19],[21] |
3.25%
|
[12],[16],[17],[22],[23],[24] |
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services (29.37%) |
|
|
|
|
|
|
|
|
|
Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
|
Investment owned, percent of net assets |
[4] |
29.37%
|
|
|
|
29.37%
|
|
|
|
Investment cost |
[2] |
$ 500,526
|
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 485,179
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services (30.59%) |
|
|
|
|
|
|
|
|
|
Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
|
Investment owned, percent of net assets |
[5] |
|
|
30.59%
|
|
|
|
30.59%
|
|
Investment cost |
[6] |
|
|
$ 444,703
|
|
|
|
|
|
Investments at Fair Value |
|
|
|
$ 428,750
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and AppDirect, Inc. Senior Secured, Maturity Date April 2026, Prime + 5.50%, Floor rate 8.75%, 7.12% Exit Fee |
|
|
|
|
|
|
|
|
|
Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[13] |
2026-04
|
|
|
|
2026-04
|
|
|
|
Investment, basis spread, variable rate |
[11],[13] |
5.50%
|
|
|
|
5.50%
|
|
|
|
Investment, interest rate, floor |
[11],[13] |
8.75%
|
|
|
|
8.75%
|
|
|
|
Principal amount |
[13] |
$ 55,790
|
|
|
|
|
|
|
|
Investment cost |
[2],[13] |
57,399
|
|
|
|
|
|
|
|
Investments at Fair Value |
[13] |
$ 59,140
|
|
|
|
|
|
|
|
Investment exit fee |
[11],[13] |
7.12%
|
|
|
|
7.12%
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and AppDirect, Inc. Senior Secured, Maturity Date April 2026, Prime + 5.50%, Floor rate 8.75%, 8.29% Exit Fee |
|
|
|
|
|
|
|
|
|
Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[10],[23] |
|
|
2026-04
|
|
|
|
2026-04
|
|
Investment, basis spread, variable rate |
[10],[12],[23] |
|
|
5.50%
|
|
|
|
5.50%
|
|
Investment, interest rate, floor |
[10],[12],[23] |
|
|
8.75%
|
|
|
|
8.75%
|
|
Principal amount |
[10],[23] |
|
|
$ 40,790
|
|
|
|
|
|
Investment cost |
[6],[10],[23] |
|
|
41,856
|
|
|
|
|
|
Investments at Fair Value |
[10],[23] |
|
|
$ 42,426
|
|
|
|
|
|
Investment exit fee |
[10],[12],[23] |
|
|
8.29%
|
|
|
|
8.29%
|
|
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and Carwow LTD Senior Secured, Maturity Date December 2024, Prime + 4.70%, Floor rate 7.95%, PIK Interest 1.45%, 4.95% Exit Fee |
|
|
|
|
|
|
|
|
|
Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2024-12
|
[7],[9],[25],[26] |
2024-12
|
[16],[27],[28] |
2024-12
|
[7],[9],[25],[26] |
2024-12
|
[16],[27],[28] |
Investment, basis spread, variable rate |
|
4.70%
|
[7],[9],[11],[25],[26] |
4.70%
|
[12],[16],[27],[28] |
4.70%
|
[7],[9],[11],[25],[26] |
4.70%
|
[12],[16],[27],[28] |
Investment, interest rate, floor |
|
7.95%
|
[7],[9],[11],[25],[26] |
7.95%
|
[12],[16],[27],[28] |
7.95%
|
[7],[9],[11],[25],[26] |
7.95%
|
[12],[16],[27],[28] |
Investment, interest rate, paid in kind |
|
1.45%
|
[7],[9],[11],[25],[26] |
1.45%
|
[12],[16],[27],[28] |
1.45%
|
[7],[9],[11],[25],[26] |
1.45%
|
[12],[16],[27],[28] |
Principal amount | £ |
|
|
|
|
|
£ 19,493
|
[7],[9],[25],[26] |
£ 18,890
|
[16],[27],[28] |
Investment cost |
|
|
|
$ 26,024
|
[6],[16],[27],[28] |
26,624
|
[2],[7],[9],[25],[26] |
|
|
Investments at Fair Value |
|
|
|
$ 22,971
|
[16],[27],[28] |
£ 24,132
|
[7],[9],[25],[26] |
|
|
Investment exit fee |
|
4.95%
|
[7],[9],[11],[25],[26] |
4.95%
|
[12],[16],[27],[28] |
4.95%
|
[7],[9],[11],[25],[26] |
4.95%
|
[12],[16],[27],[28] |
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and Houzz, Inc. Convertible Debt, Maturity Date May 2028, PIK Interest 5.50% |
|
|
|
|
|
|
|
|
|
Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[16],[29] |
|
|
2028-05
|
|
|
|
2028-05
|
|
Investment, interest rate, paid in kind |
[12],[16],[29] |
|
|
5.50%
|
|
|
|
5.50%
|
|
Principal amount |
[16],[29] |
|
|
$ 21,853
|
|
|
|
|
|
Investment cost |
[6],[16],[29] |
|
|
21,853
|
|
|
|
|
|
Investments at Fair Value |
[16],[29] |
|
|
$ 20,356
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and Houzz, Inc. Convertible Debt, Maturity Date May 2028, PIK Interest 7.00% |
|
|
|
|
|
|
|
|
|
Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[7],[30] |
2028-05
|
|
|
|
2028-05
|
|
|
|
Investment, interest rate, paid in kind |
[7],[11],[30] |
7.00%
|
|
|
|
7.00%
|
|
|
|
Principal amount |
[7],[30] |
$ 22,897
|
|
|
|
|
|
|
|
Investment cost |
[2],[7],[30] |
22,897
|
|
|
|
|
|
|
|
Investments at Fair Value |
[7],[30] |
$ 23,491
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and Jobandtalent USA, Inc. Senior Secured, Maturity Date February 2025, 1-month SOFR + 8.86%, Floor rate 9.75%, 3.00% Exit Fee |
|
|
|
|
|
|
|
|
|
Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[27],[28] |
|
|
2025-02
|
|
|
|
2025-02
|
|
Investment, basis spread, variable rate |
[12],[27],[28] |
|
|
8.86%
|
|
|
|
8.86%
|
|
Investment, interest rate, floor |
[12],[27],[28] |
|
|
9.75%
|
|
|
|
9.75%
|
|
Principal amount |
[27],[28] |
|
|
$ 14,000
|
|
|
|
|
|
Investment cost |
[6],[27],[28] |
|
|
13,853
|
|
|
|
|
|
Investments at Fair Value |
[27],[28] |
|
|
$ 13,904
|
|
|
|
|
|
Investment exit fee |
[12],[27],[28] |
|
|
3.00%
|
|
|
|
3.00%
|
|
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and Jobandtalent USA, Inc. Senior Secured, Maturity Date February 2025, 1-month SOFR + 8.86, Floor rate 9.75%, 3.00% Exit Fee |
|
|
|
|
|
|
|
|
|
Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[25],[26] |
2025-02
|
|
|
|
2025-02
|
|
|
|
Investment, basis spread, variable rate |
[11],[25],[26] |
8.86%
|
|
|
|
8.86%
|
|
|
|
Investment, interest rate, floor |
[11],[25],[26] |
9.75%
|
|
|
|
9.75%
|
|
|
|
Principal amount |
[25],[26] |
$ 14,000
|
|
|
|
|
|
|
|
Investment cost |
[2],[25],[26] |
14,030
|
|
|
|
|
|
|
|
Investments at Fair Value |
[25],[26] |
$ 14,180
|
|
|
|
|
|
|
|
Investment exit fee |
[11],[25],[26] |
3.00%
|
|
|
|
3.00%
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and Provi, Senior Secured, Maturity Date December 2026, Prime + 4.40%, Floor rate 10.65%, 2.95% Exit Fee |
|
|
|
|
|
|
|
|
|
Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2026-12
|
[1] |
2026-12
|
[31] |
2026-12
|
[1] |
2026-12
|
[31] |
Investment, basis spread, variable rate |
|
4.40%
|
[1],[11] |
4.40%
|
[12],[31] |
4.40%
|
[1],[11] |
4.40%
|
[12],[31] |
Investment, interest rate, floor |
|
10.65%
|
[1],[11] |
10.65%
|
[12],[31] |
10.65%
|
[1],[11] |
10.65%
|
[12],[31] |
Principal amount |
|
$ 15,000
|
[1] |
$ 15,000
|
[31] |
|
|
|
|
Investment cost |
|
14,860
|
[1],[2] |
14,739
|
[6],[31] |
|
|
|
|
Investments at Fair Value |
|
$ 14,938
|
[1] |
$ 14,739
|
[31] |
|
|
|
|
Investment exit fee |
|
2.95%
|
[1],[11] |
2.95%
|
[12],[31] |
2.95%
|
[1],[11] |
2.95%
|
[12],[31] |
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and RVShare, LLC, Senior Secured, Maturity Date December 2026, 3-month LIBOR + 5.50%, Floor rate 6.50%, PIK Interest 4.00% |
|
|
|
|
|
|
|
|
|
Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[10],[16],[22],[31] |
|
|
2026-12
|
|
|
|
2026-12
|
|
Investment, basis spread, variable rate |
[10],[12],[16],[22],[31] |
|
|
5.50%
|
|
|
|
5.50%
|
|
Investment, interest rate, floor |
[10],[12],[16],[22],[31] |
|
|
6.50%
|
|
|
|
6.50%
|
|
Investment, interest rate, paid in kind |
[10],[12],[16],[22],[31] |
|
|
4.00%
|
|
|
|
4.00%
|
|
Principal amount |
[10],[16],[22],[31] |
|
|
$ 27,730
|
|
|
|
|
|
Investment cost |
[6],[10],[16],[22],[31] |
|
|
27,265
|
|
|
|
|
|
Investments at Fair Value |
[10],[16],[22],[31] |
|
|
$ 27,256
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and RVShare, LLC, Senior Secured, Maturity Date December 2026, 3-month SOFR + 5.50%, Floor rate 6.50%, PIK Interest 4.00% |
|
|
|
|
|
|
|
|
|
Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[1],[7],[8],[9] |
2026-12
|
|
|
|
2026-12
|
|
|
|
Investment, basis spread, variable rate |
[1],[7],[8],[9],[11] |
5.50%
|
|
|
|
5.50%
|
|
|
|
Investment, interest rate, floor |
[1],[7],[8],[9],[11] |
6.50%
|
|
|
|
6.50%
|
|
|
|
Investment, interest rate, paid in kind |
[1],[7],[8],[9],[11] |
4.00%
|
|
|
|
4.00%
|
|
|
|
Principal amount |
[1],[7],[8],[9] |
$ 28,586
|
|
|
|
|
|
|
|
Investment cost |
[1],[2],[7],[8],[9] |
28,212
|
|
|
|
|
|
|
|
Investments at Fair Value |
[1],[7],[8],[9] |
$ 28,413
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and Rhino Labs, Inc. Senior Secured, Maturity Date March 2024, Prime + 5.50%, Floor rate 8.75%, PIK Interest 2.25% |
|
|
|
|
|
|
|
|
|
Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2024-03
|
|
2024-03
|
[16],[31] |
2024-03
|
|
2024-03
|
[16],[31] |
Investment, basis spread, variable rate |
|
5.50%
|
[11] |
5.50%
|
[12],[16],[31] |
5.50%
|
[11] |
5.50%
|
[12],[16],[31] |
Investment, interest rate, floor |
|
8.75%
|
[11] |
8.75%
|
[12],[16],[31] |
8.75%
|
[11] |
8.75%
|
[12],[16],[31] |
Investment, interest rate, paid in kind |
|
2.25%
|
[11] |
2.25%
|
[12],[16],[31] |
2.25%
|
[11] |
2.25%
|
[12],[16],[31] |
Principal amount |
|
$ 9,069
|
|
$ 16,500
|
[16],[31] |
|
|
|
|
Investment cost |
|
9,039
|
[2] |
16,328
|
[6],[16],[31] |
|
|
|
|
Investments at Fair Value |
|
$ 9,039
|
|
$ 16,496
|
[16],[31] |
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and Riviera Partners LLC. Senior Secured, Maturity Date April 2027, 3-month SOFR + 7.53%, Floor rate 8.53% |
|
|
|
|
|
|
|
|
|
Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[9],[20] |
2027-04
|
|
|
|
2027-04
|
|
|
|
Investment, basis spread, variable rate |
[9],[11],[20] |
7.53%
|
|
|
|
7.53%
|
|
|
|
Investment, interest rate, floor |
[9],[11],[20] |
8.53%
|
|
|
|
8.53%
|
|
|
|
Principal amount |
[9],[20] |
$ 25,922
|
|
|
|
|
|
|
|
Investment cost |
[2],[9],[20] |
25,438
|
|
|
|
|
|
|
|
Investments at Fair Value |
[9],[20] |
25,060
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and SeatGeek, Inc. |
|
|
|
|
|
|
|
|
|
Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
|
Principal amount |
|
102,718
|
|
|
|
|
|
|
|
Investment cost |
[2] |
102,086
|
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 102,301
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and SeatGeek, Inc. Senior Secured, Maturity Date July 2025, Prime + 2.50%, Floor rate 10.75%, PIK Interest 0.50% |
|
|
|
|
|
|
|
|
|
Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[7],[13],[21] |
2025-07
|
|
|
|
2025-07
|
|
|
|
Investment, basis spread, variable rate |
[7],[11],[13],[21] |
2.50%
|
|
|
|
2.50%
|
|
|
|
Investment, interest rate, floor |
[7],[11],[13],[21] |
10.75%
|
|
|
|
10.75%
|
|
|
|
Investment, interest rate, paid in kind |
[7],[11],[13],[21] |
0.50%
|
|
|
|
0.50%
|
|
|
|
Principal amount |
[7],[13],[21] |
$ 77,551
|
|
|
|
|
|
|
|
Investment cost |
[2],[7],[13],[21] |
77,019
|
|
|
|
|
|
|
|
Investments at Fair Value |
[7],[13],[21] |
$ 77,019
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and SeatGeek, Inc. Senior Secured, Maturity Date June 2023, Prime + 5.00%, Floor rate 10.50%, PIK Interest 0.50% |
|
|
|
|
|
|
|
|
|
Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[16],[22],[23],[24] |
|
|
2023-06
|
|
|
|
2023-06
|
|
Investment, basis spread, variable rate |
[12],[16],[22],[23],[24] |
|
|
5.00%
|
|
|
|
5.00%
|
|
Investment, interest rate, floor |
[12],[16],[22],[23],[24] |
|
|
10.50%
|
|
|
|
10.50%
|
|
Investment, interest rate, paid in kind |
[12],[16],[22],[23],[24] |
|
|
0.50%
|
|
|
|
0.50%
|
|
Principal amount |
[16],[22],[23],[24] |
|
|
$ 60,915
|
|
|
|
|
|
Investment cost |
[6],[16],[22],[23],[24] |
|
|
60,721
|
|
|
|
|
|
Investments at Fair Value |
[16],[22],[23],[24] |
|
|
$ 60,721
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and SeatGeek, Inc. Senior Secured, Maturity Date May 2026, Prime + 7.00%, Floor rate 10.50%, PIK Interest 0.50% |
|
|
|
|
|
|
|
|
|
Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[16],[17],[24] |
|
|
2026-05
|
|
|
|
2026-05
|
|
Investment, basis spread, variable rate |
[12],[16],[17],[24] |
|
|
7.00%
|
|
|
|
7.00%
|
|
Investment, interest rate, floor |
[12],[16],[17],[24] |
|
|
10.50%
|
|
|
|
10.50%
|
|
Investment, interest rate, paid in kind |
[12],[16],[17],[24] |
|
|
0.50%
|
|
|
|
0.50%
|
|
Principal amount |
[16],[17],[24] |
|
|
$ 25,071
|
|
|
|
|
|
Investment cost |
[6],[16],[17],[24] |
|
|
24,912
|
|
|
|
|
|
Investments at Fair Value |
[16],[17],[24] |
|
|
$ 25,823
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and SeatGeek, Inc., Senior Secured, Maturity Date May 2026, Prime + 7.00%, Floor rate 10.50%, PIK Interest 0.05%, 1.00% Exit Fee |
|
|
|
|
|
|
|
|
|
Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[7],[19],[21] |
2026-05
|
|
|
|
2026-05
|
|
|
|
Investment, basis spread, variable rate |
[7],[11],[19],[21] |
7.00%
|
|
|
|
7.00%
|
|
|
|
Investment, interest rate, floor |
[7],[11],[19],[21] |
10.50%
|
|
|
|
10.50%
|
|
|
|
Investment, interest rate, cap |
[7],[11],[19],[21] |
0.50%
|
|
|
|
0.50%
|
|
|
|
Principal amount |
[7],[19],[21] |
$ 25,167
|
|
|
|
|
|
|
|
Investment cost |
[2],[7],[19],[21] |
25,067
|
|
|
|
|
|
|
|
Investments at Fair Value |
[7],[19],[21] |
$ 25,282
|
|
|
|
|
|
|
|
Investment exit fee |
[7],[11],[19],[21] |
1.00%
|
|
|
|
1.00%
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and Skyword, Inc. Senior Secured, Maturity Date November 2026, Prime + 2.75%, Floor rate 9.25%, PIK Interest 1.75%, 3.00% Exit Fee |
|
|
|
|
|
|
|
|
|
Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2026-11
|
[7],[8] |
2026-11
|
[16],[22] |
2026-11
|
[7],[8] |
2026-11
|
[16],[22] |
Investment, basis spread, variable rate |
|
2.75%
|
[7],[8],[11] |
2.75%
|
[12],[16],[22] |
2.75%
|
[7],[8],[11] |
2.75%
|
[12],[16],[22] |
Investment, interest rate, floor |
|
9.25%
|
[7],[8],[11] |
9.25%
|
[12],[16],[22] |
9.25%
|
[7],[8],[11] |
9.25%
|
[12],[16],[22] |
Investment, interest rate, paid in kind |
|
1.75%
|
[7],[8],[11] |
1.75%
|
[12],[16],[22] |
1.75%
|
[7],[8],[11] |
1.75%
|
[12],[16],[22] |
Principal amount |
|
$ 9,128
|
[7],[8] |
$ 9,007
|
[16],[22] |
|
|
|
|
Investment cost |
|
9,120
|
[2],[7],[8] |
8,918
|
[6],[16],[22] |
|
|
|
|
Investments at Fair Value |
|
$ 9,222
|
[7],[8] |
$ 8,870
|
[16],[22] |
|
|
|
|
Investment exit fee |
|
3.00%
|
[7],[8],[11] |
3.00%
|
[12],[16],[22] |
3.00%
|
[7],[8],[11] |
3.00%
|
[12],[16],[22] |
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and Tectura Corporation, Senior Secured, Maturity Date July 2024 One, PIK Interest 5.00% |
|
|
|
|
|
|
|
|
|
Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2024-07
|
[7],[32],[33] |
2024-07
|
[16],[34],[35] |
2024-07
|
[7],[32],[33] |
2024-07
|
[16],[34],[35] |
Investment, interest rate, paid in kind |
|
5.00%
|
[7],[11],[32],[33] |
5.00%
|
[12],[16],[34],[35] |
5.00%
|
[7],[11],[32],[33] |
5.00%
|
[12],[16],[34],[35] |
Principal amount |
|
$ 23,703
|
[7],[32],[33] |
$ 10,680
|
[16],[34],[35] |
|
|
|
|
Investment cost |
|
13,263
|
[2],[7],[32],[33] |
240
|
[6],[16],[34],[35] |
|
|
|
|
Investments at Fair Value |
|
$ 0
|
[7],[32],[33] |
$ 0
|
[16],[34],[35] |
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and Tectura Corporation, Senior Secured, Maturity Date July 2024 Two, PIK Interest 5.00% |
|
|
|
|
|
|
|
|
|
Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[16],[34],[35] |
|
|
2024-07
|
|
|
|
2024-07
|
|
Investment, interest rate, paid in kind |
[12],[16],[34],[35] |
|
|
5.00%
|
|
|
|
5.00%
|
|
Principal amount |
[16],[34],[35] |
|
|
$ 13,023
|
|
|
|
|
|
Investment cost |
[6],[16],[34],[35] |
|
|
13,023
|
|
|
|
|
|
Investments at Fair Value |
[16],[34],[35] |
|
|
$ 0
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and Tectura Corporation, Senior Secured, Maturity Date July 2024, FIXED 8.25% |
|
|
|
|
|
|
|
|
|
Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2024-07
|
[32] |
2024-07
|
[16],[34],[35] |
2024-07
|
[32] |
2024-07
|
[16],[34],[35] |
Investment, interest rate, paid in cash |
|
8.25%
|
[11],[32] |
8.25%
|
[12],[16],[34],[35] |
8.25%
|
[11],[32] |
8.25%
|
[12],[16],[34],[35] |
Principal amount |
|
$ 8,250
|
[32] |
$ 8,250
|
[16],[34],[35] |
|
|
|
|
Investment cost |
|
8,250
|
[2],[32] |
8,250
|
[6],[16],[34],[35] |
|
|
|
|
Investments at Fair Value |
|
$ 6,243
|
[32] |
$ 8,042
|
[16],[34],[35] |
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and Thumbtack, Inc. Senior Secured, Maturity Date April 2026, Prime + 4.95%, Floor rate 8.20%, PIK Interest 1.50%, 3.95% Exit Fee |
|
|
|
|
|
|
|
|
|
Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2026-04
|
[7],[9],[13] |
2026-04
|
[10],[16],[23] |
2026-04
|
[7],[9],[13] |
2026-04
|
[10],[16],[23] |
Investment, basis spread, variable rate |
|
4.95%
|
[7],[9],[11],[13] |
4.95%
|
[10],[12],[16],[23] |
4.95%
|
[7],[9],[11],[13] |
4.95%
|
[10],[12],[16],[23] |
Investment, interest rate, floor |
|
8.20%
|
[7],[9],[11],[13] |
8.20%
|
[10],[12],[16],[23] |
8.20%
|
[7],[9],[11],[13] |
8.20%
|
[10],[12],[16],[23] |
Investment, interest rate, paid in kind |
|
1.50%
|
[7],[9],[11],[13] |
1.50%
|
[10],[12],[16],[23] |
1.50%
|
[7],[9],[11],[13] |
1.50%
|
[10],[12],[16],[23] |
Principal amount |
|
$ 10,219
|
[7],[9],[13] |
$ 10,103
|
[10],[16],[23] |
|
|
|
|
Investment cost |
|
10,248
|
[2],[7],[9],[13] |
10,050
|
[6],[10],[16],[23] |
|
|
|
|
Investments at Fair Value |
|
$ 10,546
|
[7],[9],[13] |
$ 10,167
|
[10],[16],[23] |
|
|
|
|
Investment exit fee |
|
3.95%
|
[7],[9],[11],[13] |
3.95%
|
[10],[12],[16],[23] |
3.95%
|
[7],[9],[11],[13] |
3.95%
|
[10],[12],[16],[23] |
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and Udacity, Inc. Senior Secured, Maturity Date September 2024, Prime + 4.50%, Floor rate 7.75%, PIK Interest 2.00%, 3.00% Exit Fee |
|
|
|
|
|
|
|
|
|
Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2024-09
|
[7],[13] |
2024-09
|
[16],[23] |
2024-09
|
[7],[13] |
2024-09
|
[16],[23] |
Investment, basis spread, variable rate |
|
4.50%
|
[7],[11],[13] |
4.50%
|
[12],[16],[23] |
4.50%
|
[7],[11],[13] |
4.50%
|
[12],[16],[23] |
Investment, interest rate, floor |
|
7.75%
|
[7],[11],[13] |
7.75%
|
[12],[16],[23] |
7.75%
|
[7],[11],[13] |
7.75%
|
[12],[16],[23] |
Investment, interest rate, paid in kind |
|
2.00%
|
[7],[11],[13] |
2.00%
|
[12],[16],[23] |
2.00%
|
[7],[11],[13] |
2.00%
|
[12],[16],[23] |
Principal amount |
|
$ 52,733
|
[7],[13] |
$ 51,937
|
[16],[23] |
|
|
|
|
Investment cost |
|
53,544
|
[2],[7],[13] |
52,265
|
[6],[16],[23] |
|
|
|
|
Investments at Fair Value |
|
$ 52,559
|
[7],[13] |
$ 52,976
|
[16],[23] |
|
|
|
|
Investment exit fee |
|
3.00%
|
[7],[11],[13] |
3.00%
|
[12],[16],[23] |
3.00%
|
[7],[11],[13] |
3.00%
|
[12],[16],[23] |
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and Veem, Inc. Senior Secured, Maturity Date March 2025, Prime + 4.00%, Floor rate 7.25%, PIK Interest 1.25%, 4.50% Exit Fee |
|
|
|
|
|
|
|
|
|
Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2025-03
|
[7],[8] |
2025-03
|
[16],[22] |
2025-03
|
[7],[8] |
2025-03
|
[16],[22] |
Investment, basis spread, variable rate |
|
4.00%
|
[7],[8],[11] |
4.00%
|
[12],[16],[22] |
4.00%
|
[7],[8],[11] |
4.00%
|
[12],[16],[22] |
Investment, interest rate, floor |
|
7.25%
|
[7],[8],[11] |
7.25%
|
[12],[16],[22] |
7.25%
|
[7],[8],[11] |
7.25%
|
[12],[16],[22] |
Investment, interest rate, paid in kind |
|
1.25%
|
[7],[8],[11] |
1.25%
|
[12],[16],[22] |
1.25%
|
[7],[8],[11] |
1.25%
|
[12],[16],[22] |
Principal amount |
|
$ 5,091
|
[7],[8] |
$ 5,043
|
[16],[22] |
|
|
|
|
Investment cost |
|
5,130
|
[2],[7],[8] |
5,000
|
[6],[16],[22] |
|
|
|
|
Investments at Fair Value |
|
$ 5,193
|
[7],[8] |
$ 5,042
|
[16],[22] |
|
|
|
|
Investment exit fee |
|
4.50%
|
[7],[8],[11] |
4.50%
|
[12],[16],[22] |
4.50%
|
[7],[8],[11] |
4.50%
|
[12],[16],[22] |
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and Veem, Inc. Senior Secured, Maturity Date March 2025, Prime + 4.70%, Floor rate 7.95%, PIK Interest 1.50%, 4.50% Exit Fee |
|
|
|
|
|
|
|
|
|
Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2025-03
|
[7],[13] |
2025-03
|
[16] |
2025-03
|
[7],[13] |
2025-03
|
[16] |
Investment, basis spread, variable rate |
|
4.70%
|
[7],[11],[13] |
4.70%
|
[12],[16] |
4.70%
|
[7],[11],[13] |
4.70%
|
[12],[16] |
Investment, interest rate, floor |
|
7.95%
|
[7],[11],[13] |
7.95%
|
[12],[16] |
7.95%
|
[7],[11],[13] |
7.95%
|
[12],[16] |
Investment, interest rate, paid in kind |
|
1.50%
|
[7],[11],[13] |
1.50%
|
[12],[16] |
1.50%
|
[7],[11],[13] |
1.50%
|
[12],[16] |
Principal amount |
|
$ 5,091
|
[7],[13] |
$ 5,033
|
[16] |
|
|
|
|
Investment cost |
|
5,142
|
[2],[7],[13] |
4,988
|
[6],[16] |
|
|
|
|
Investments at Fair Value |
|
$ 5,256
|
[7],[13] |
$ 5,124
|
[16] |
|
|
|
|
Investment exit fee |
|
4.50%
|
[7],[11],[13] |
4.50%
|
[12],[16] |
4.50%
|
[7],[11],[13] |
4.50%
|
[12],[16] |
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and Worldremit Group Limited |
|
|
|
|
|
|
|
|
|
Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
|
Principal amount |
|
$ 94,500
|
|
|
|
|
|
|
|
Investment cost |
[2] |
95,244
|
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 95,466
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and Worldremit Group Limited, Senior Secured, Maturity Date February 2025, 1-month SOFR + 9.35%, Floor rate 10.25%, 3.20% Exit Fee |
|
|
|
|
|
|
|
|
|
Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[14],[21],[25],[26] |
2025-02
|
|
|
|
2025-02
|
|
|
|
Investment, basis spread, variable rate |
[11],[14],[21],[25],[26] |
9.35%
|
|
|
|
9.35%
|
|
|
|
Investment, interest rate, floor |
[11],[14],[21],[25],[26] |
10.25%
|
|
|
|
10.25%
|
|
|
|
Principal amount |
[14],[21],[25],[26] |
$ 6,250
|
|
|
|
|
|
|
|
Investment cost |
[2],[14],[21],[25],[26] |
6,279
|
|
|
|
|
|
|
|
Investments at Fair Value |
[14],[21],[25],[26] |
$ 6,304
|
|
|
|
|
|
|
|
Investment exit fee |
[11],[14],[21],[25],[26] |
3.20%
|
|
|
|
3.20%
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and Worldremit Group Limited, Senior Secured, Maturity Date February 2025, 3-month LIBOR + 9.25%, Floor rate 10.25%, 3.00% Exit Fee |
|
|
|
|
|
|
|
|
|
Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[15],[17],[23],[24],[27],[28] |
|
|
2025-02
|
|
|
|
2025-02
|
|
Investment, basis spread, variable rate |
[12],[15],[17],[23],[24],[27],[28] |
|
|
9.25%
|
|
|
|
9.25%
|
|
Investment, interest rate, floor |
[12],[15],[17],[23],[24],[27],[28] |
|
|
10.25%
|
|
|
|
10.25%
|
|
Principal amount |
[15],[17],[23],[24],[27],[28] |
|
|
$ 94,500
|
|
|
|
|
|
Investment cost |
[6],[15],[17],[23],[24],[27],[28] |
|
|
94,418
|
|
|
|
|
|
Investments at Fair Value |
[15],[17],[23],[24],[27],[28] |
|
|
$ 93,837
|
|
|
|
|
|
Investment exit fee |
[12],[15],[17],[23],[24],[27],[28] |
|
|
3.00%
|
|
|
|
3.00%
|
|
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and Worldremit Group Limited, Senior Secured, Maturity Date February 2025, 3-month SOFR + 9.40%, Floor rate 10.25%, 3.20% Exit Fee |
|
|
|
|
|
|
|
|
|
Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[13],[14],[19],[21],[25],[26] |
2025-02
|
|
|
|
2025-02
|
|
|
|
Investment, basis spread, variable rate |
[11],[13],[14],[19],[21],[25],[26] |
9.40%
|
|
|
|
9.40%
|
|
|
|
Investment, interest rate, floor |
[11],[13],[14],[19],[21],[25],[26] |
10.25%
|
|
|
|
10.25%
|
|
|
|
Principal amount |
[13],[14],[19],[21],[25],[26] |
$ 88,250
|
|
|
|
|
|
|
|
Investment cost |
[2],[13],[14],[19],[21],[25],[26] |
88,965
|
|
|
|
|
|
|
|
Investments at Fair Value |
[13],[14],[19],[21],[25],[26] |
$ 89,162
|
|
|
|
|
|
|
|
Investment exit fee |
[11],[13],[14],[19],[21],[25],[26] |
3.20%
|
|
|
|
3.20%
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services, SeatGeek, Inc. |
|
|
|
|
|
|
|
|
|
Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
|
Principal amount |
|
|
|
$ 85,986
|
|
|
|
|
|
Investment cost |
[6] |
|
|
85,633
|
|
|
|
|
|
Investments at Fair Value |
|
|
|
86,544
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services, Tectura Corporation |
|
|
|
|
|
|
|
|
|
Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
|
Principal amount |
|
$ 31,953
|
|
31,953
|
|
|
|
|
|
Investment cost |
|
21,513
|
[2] |
21,513
|
[6] |
|
|
|
|
Investments at Fair Value |
|
6,243
|
|
8,042
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services, Veem, Inc. |
|
|
|
|
|
|
|
|
|
Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
|
Principal amount |
|
10,182
|
|
10,076
|
|
|
|
|
|
Investment cost |
|
10,272
|
[2] |
9,988
|
[6] |
|
|
|
|
Investments at Fair Value |
|
$ 10,449
|
|
$ 10,166
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Diversified Financial Services (2.40%) |
|
|
|
|
|
|
|
|
|
Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
|
Investment owned, percent of net assets |
[5] |
|
|
2.40%
|
|
|
|
2.40%
|
|
Investment cost |
[6] |
|
|
$ 36,567
|
|
|
|
|
|
Investments at Fair Value |
|
|
|
$ 33,700
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Diversified Financial Services (3.44%) |
|
|
|
|
|
|
|
|
|
Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
|
Investment owned, percent of net assets |
[4] |
3.44%
|
|
|
|
3.44%
|
|
|
|
Investment cost |
[2] |
$ 56,573
|
|
|
|
|
|
|
|
Investments at Fair Value |
|
56,872
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Diversified Financial Services and Gibraltar Acquisition, LLC (p.k.a. Gibraltar Business Capital, LLC) |
|
|
|
|
|
|
|
|
|
Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
|
Principal amount |
|
35,000
|
|
|
|
|
|
|
|
Investment cost |
[2] |
34,439
|
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 34,439
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Diversified Financial Services and Gibraltar Acquisition, LLC (p.k.a. Gibraltar Business Capital, LLC), UnSecured, Maturity Date September 2026, Fixed + 11.95% |
|
|
|
|
|
|
|
|
|
Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[32],[36] |
2026-09
|
|
|
|
2026-09
|
|
|
|
Investment, interest rate, paid in cash |
[11],[32],[36] |
11.95%
|
|
|
|
11.95%
|
|
|
|
Principal amount |
[32],[36] |
$ 10,000
|
|
|
|
|
|
|
|
Investment cost |
[2],[32],[36] |
9,801
|
|
|
|
|
|
|
|
Investments at Fair Value |
[32],[36] |
$ 9,801
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Diversified Financial Services and Gibraltar Acquisition, LLC (p.k.a. Gibraltar Business Capital, LLC), Unsecured, Maturity Date September 2026, FIXED 11.50% |
|
|
|
|
|
|
|
|
|
Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[32],[36] |
2026-09
|
|
|
|
2026-09
|
|
|
|
Investment, interest rate, paid in cash |
[11],[32],[36] |
11.50%
|
|
|
|
11.50%
|
|
|
|
Principal amount |
[32],[36] |
$ 25,000
|
|
|
|
|
|
|
|
Investment cost |
[2],[32],[36] |
24,638
|
|
|
|
|
|
|
|
Investments at Fair Value |
[32],[36] |
$ 24,638
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Diversified Financial Services and Gibraltar Business Capital, LLC, Unsecured, Maturity Date September 2026, FIXED 11.50% |
|
|
|
|
|
|
|
|
|
Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[34] |
|
|
2026-09
|
|
|
|
2026-09
|
|
Investment, interest rate, paid in cash |
[12],[34] |
|
|
11.50%
|
|
|
|
11.50%
|
|
Principal amount |
[34] |
|
|
$ 10,000
|
|
|
|
|
|
Investment cost |
[6],[34] |
|
|
9,852
|
|
|
|
|
|
Investments at Fair Value |
[34] |
|
|
$ 8,898
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Diversified Financial Services and Gibraltar Business Capital, LLC, Unsecured, Maturity Date September 2026, FIXED 14.50% |
|
|
|
|
|
|
|
|
|
Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[34] |
|
|
2026-09
|
|
|
|
2026-09
|
|
Investment, interest rate, paid in cash |
[12],[34] |
|
|
14.50%
|
|
|
|
14.50%
|
|
Principal amount |
[34] |
|
|
$ 15,000
|
|
|
|
|
|
Investment cost |
[6],[34] |
|
|
14,715
|
|
|
|
|
|
Investments at Fair Value |
[34] |
|
|
$ 12,802
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Diversified Financial Services and Hercules Adviser LLC, Unsecured, Maturity Date June 2025, FIXED 5.00% |
|
|
|
|
|
|
|
|
|
Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2025-06
|
[32],[37] |
2025-06
|
[34] |
2025-06
|
[32],[37] |
2025-06
|
[34] |
Investment, interest rate, paid in cash |
|
5.00%
|
[11],[32],[37] |
5.00%
|
[12],[34] |
5.00%
|
[11],[32],[37] |
5.00%
|
[12],[34] |
Principal amount |
|
$ 12,000
|
[32],[37] |
$ 12,000
|
[34] |
|
|
|
|
Investment cost |
|
12,000
|
[2],[32],[37] |
12,000
|
[6],[34] |
|
|
|
|
Investments at Fair Value |
|
$ 12,000
|
[32],[37] |
12,000
|
[34] |
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Diversified Financial Services and Next Insurance, Inc, Senior Secured, Maturity Date February 2028, Prime + -1.50%, Floor rate 4.75%, PIK Interest 5.50% |
|
|
|
|
|
|
|
|
|
Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[7],[9],[14] |
2028-02
|
|
|
|
2028-02
|
|
|
|
Investment, basis spread, variable rate |
[7],[9],[11],[14] |
(1.50%)
|
|
|
|
(1.50%)
|
|
|
|
Investment, interest rate, floor |
[7],[9],[11],[14] |
4.75%
|
|
|
|
4.75%
|
|
|
|
Investment, interest rate, paid in kind |
[7],[9],[11],[14] |
5.50%
|
|
|
|
5.50%
|
|
|
|
Principal amount |
[7],[9],[14] |
$ 10,325
|
|
|
|
|
|
|
|
Investment cost |
[2],[7],[9],[14] |
10,134
|
|
|
|
|
|
|
|
Investments at Fair Value |
[7],[9],[14] |
$ 10,433
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Diversified Financial Services, Gibraltar Business Capital, LLC, Unsecured |
|
|
|
|
|
|
|
|
|
Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
|
Principal amount |
|
|
|
25,000
|
|
|
|
|
|
Investment cost |
[6] |
|
|
24,567
|
|
|
|
|
|
Investments at Fair Value |
|
|
|
$ 21,700
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development (69.33%) |
|
|
|
|
|
|
|
|
|
Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
|
Investment owned, percent of net assets |
[4] |
69.33%
|
|
|
|
69.33%
|
|
|
|
Investment cost |
[2] |
$ 1,132,403
|
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 1,145,410
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development (78.59%) |
|
|
|
|
|
|
|
|
|
Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
|
Investment owned, percent of net assets |
[5] |
|
|
78.59%
|
|
|
|
78.59%
|
|
Investment cost |
[6] |
|
|
$ 1,107,352
|
|
|
|
|
|
Investments at Fair Value |
|
|
|
$ 1,101,430
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and ATAI Life Sciences N.V. Senior Secured, Maturity Date August 2026, Prime + 4.55%, Floor rate 8.55%, 6.95% Exit Fee |
|
|
|
|
|
|
|
|
|
Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2026-08
|
[25],[26] |
2026-08
|
[27],[28] |
2026-08
|
[25],[26] |
2026-08
|
[27],[28] |
Investment, basis spread, variable rate |
|
4.55%
|
[11],[25],[26] |
4.55%
|
[12],[27],[28] |
4.55%
|
[11],[25],[26] |
4.55%
|
[12],[27],[28] |
Investment, interest rate, floor |
|
8.55%
|
[11],[25],[26] |
8.55%
|
[12],[27],[28] |
8.55%
|
[11],[25],[26] |
8.55%
|
[12],[27],[28] |
Principal amount |
|
$ 10,500
|
[25],[26] |
$ 10,500
|
[27],[28] |
|
|
|
|
Investment cost |
|
10,643
|
[2],[25],[26] |
10,513
|
[6],[27],[28] |
|
|
|
|
Investments at Fair Value |
|
$ 10,783
|
[25],[26] |
$ 10,513
|
[27],[28] |
|
|
|
|
Investment exit fee |
|
6.95%
|
[11],[25],[26] |
6.95%
|
[12],[27],[28] |
6.95%
|
[11],[25],[26] |
6.95%
|
[12],[27],[28] |
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Akero Therapeutics, Inc. Senior Secured, Maturity Date January 2027, Prime + 3.65%, Floor rate 7.65%, 5.85% Exit Fee |
|
|
|
|
|
|
|
|
|
Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2027-01
|
[8],[9],[25] |
2027-01
|
[10],[22],[27] |
2027-01
|
[8],[9],[25] |
2027-01
|
[10],[22],[27] |
Investment, basis spread, variable rate |
|
3.65%
|
[8],[9],[11],[25] |
3.65%
|
[10],[12],[22],[27] |
3.65%
|
[8],[9],[11],[25] |
3.65%
|
[10],[12],[22],[27] |
Investment, interest rate, floor |
|
7.65%
|
[8],[9],[11],[25] |
7.65%
|
[10],[12],[22],[27] |
7.65%
|
[8],[9],[11],[25] |
7.65%
|
[10],[12],[22],[27] |
Principal amount |
|
$ 12,500
|
[8],[9],[25] |
$ 5,000
|
[10],[22],[27] |
|
|
|
|
Investment cost |
|
12,454
|
[2],[8],[9],[25] |
4,986
|
[6],[10],[22],[27] |
|
|
|
|
Investments at Fair Value |
|
$ 12,948
|
[8],[9],[25] |
$ 5,039
|
[10],[22],[27] |
|
|
|
|
Investment exit fee |
|
5.85%
|
[8],[9],[11],[25] |
5.85%
|
[10],[12],[22],[27] |
5.85%
|
[8],[9],[11],[25] |
5.85%
|
[10],[12],[22],[27] |
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Aldeyra Therapeutics, Inc. Senior Secured, Maturity Date October 2024, Prime + 3.10%, Floor rate 8.60%, 8.90% Exit Fee |
|
|
|
|
|
|
|
|
|
Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2024-10
|
[19] |
2024-10
|
[17] |
2024-10
|
[19] |
2024-10
|
[17] |
Investment, basis spread, variable rate |
|
3.10%
|
[11],[19] |
3.10%
|
[12],[17] |
3.10%
|
[11],[19] |
3.10%
|
[12],[17] |
Investment, interest rate, floor |
|
8.60%
|
[11],[19] |
8.60%
|
[12],[17] |
8.60%
|
[11],[19] |
8.60%
|
[12],[17] |
Principal amount |
|
$ 15,000
|
[19] |
$ 15,000
|
[17] |
|
|
|
|
Investment cost |
|
16,137
|
[2],[19] |
15,879
|
[6],[17] |
|
|
|
|
Investments at Fair Value |
|
$ 16,296
|
[19] |
$ 15,974
|
[17] |
|
|
|
|
Investment exit fee |
|
8.90%
|
[11],[19] |
8.90%
|
[12],[17] |
8.90%
|
[11],[19] |
8.90%
|
[12],[17] |
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Alladapt Immunotherapeutics Inc. Senior Secured, Maturity Date September 2026, Prime + 3.65%, Floor rate 8.40%, Cap rate 10.90%, 10.60% Exit Fee |
|
|
|
|
|
|
|
|
|
Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[10],[22] |
|
|
2026-09
|
|
|
|
2026-09
|
|
Investment, basis spread, variable rate |
[10],[12],[22] |
|
|
3.65%
|
|
|
|
3.65%
|
|
Investment, interest rate, floor |
[10],[12],[22] |
|
|
8.40%
|
|
|
|
8.40%
|
|
Investment, interest rate, cap |
[10],[12],[22] |
|
|
10.90%
|
|
|
|
10.90%
|
|
Principal amount |
[10],[22] |
|
|
$ 15,000
|
|
|
|
|
|
Investment cost |
[6],[10],[22] |
|
|
14,920
|
|
|
|
|
|
Investments at Fair Value |
[10],[22] |
|
|
$ 14,920
|
|
|
|
|
|
Investment exit fee |
[10],[12],[22] |
|
|
10.60%
|
|
|
|
10.60%
|
|
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Alladapt Immunotherapeutics Inc. Senior Secured, Maturity Date September 2026, Prime + 3.65%, Floor rate 8.40%, Cap rate 10.90%, 5.30% Exit Fee |
|
|
|
|
|
|
|
|
|
Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[8] |
2026-09
|
|
|
|
2026-09
|
|
|
|
Investment, basis spread, variable rate |
[8],[11] |
3.65%
|
|
|
|
3.65%
|
|
|
|
Investment, interest rate, floor |
[8],[11] |
8.40%
|
|
|
|
8.40%
|
|
|
|
Investment, interest rate, cap |
[8],[11] |
10.90%
|
|
|
|
10.90%
|
|
|
|
Principal amount |
[8] |
$ 35,000
|
|
|
|
|
|
|
|
Investment cost |
[2],[8] |
35,002
|
|
|
|
|
|
|
|
Investments at Fair Value |
[8] |
$ 35,016
|
|
|
|
|
|
|
|
Investment exit fee |
[8],[11] |
5.30%
|
|
|
|
5.30%
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and AmplifyBio, LLC, Senior Secured, Maturity Date January 2027, Prime + 2.50%, Floor rate 9.50%, Cap rate 10.75%, 5.85% Exit Fee |
|
|
|
|
|
|
|
|
|
Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2027-01
|
[1] |
2027-01
|
[31] |
2027-01
|
[1] |
2027-01
|
[31] |
Investment, basis spread, variable rate |
|
2.50%
|
[1],[11] |
2.50%
|
[12],[31] |
2.50%
|
[1],[11] |
2.50%
|
[12],[31] |
Investment, interest rate, floor |
|
9.50%
|
[1],[11] |
9.50%
|
[12],[31] |
9.50%
|
[1],[11] |
9.50%
|
[12],[31] |
Investment, interest rate, cap |
|
10.75%
|
[1],[11] |
10.75%
|
[12],[31] |
10.75%
|
[1],[11] |
10.75%
|
[12],[31] |
Principal amount |
|
$ 24,000
|
[1] |
$ 24,000
|
[31] |
|
|
|
|
Investment cost |
|
24,000
|
[1],[2] |
23,663
|
[6],[31] |
|
|
|
|
Investments at Fair Value |
|
$ 23,989
|
[1] |
$ 23,663
|
[31] |
|
|
|
|
Investment exit fee |
|
5.85%
|
[1],[11] |
5.85%
|
[12],[31] |
5.85%
|
[1],[11] |
5.85%
|
[12],[31] |
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Aveo Pharmaceuticals, Inc. Senior Secured, Maturity Date September 2024, Prime + 6.40%, Floor rate 9.65%, Cap rate 15.00%, 6.95% Exit Fee |
|
|
|
|
|
|
|
|
|
Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[17],[31] |
|
|
2024-09
|
|
|
|
2024-09
|
|
Investment, basis spread, variable rate |
[12],[17],[31] |
|
|
6.40%
|
|
|
|
6.40%
|
|
Investment, interest rate, floor |
[12],[17],[31] |
|
|
9.65%
|
|
|
|
9.65%
|
|
Investment, interest rate, cap |
[12],[17],[31] |
|
|
15.00%
|
|
|
|
15.00%
|
|
Principal amount |
[17],[31] |
|
|
$ 40,000
|
|
|
|
|
|
Investment cost |
[6],[17],[31] |
|
|
41,644
|
|
|
|
|
|
Investments at Fair Value |
[17],[31] |
|
|
$ 43,183
|
|
|
|
|
|
Investment exit fee |
[12],[17],[31] |
|
|
6.95%
|
|
|
|
6.95%
|
|
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Axsome Therapeutics, Inc. Senior Secured, Maturity Date January 2028 Prime + 2.20%, Floor rate 9.95%, Cap rate 10.70%, 5.78% Exit Fee |
|
|
|
|
|
|
|
|
|
Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[9],[13],[19],[21],[25] |
2028-01
|
|
|
|
2028-01
|
|
|
|
Investment, basis spread, variable rate |
[9],[11],[13],[19],[21],[25] |
2.20%
|
|
|
|
2.20%
|
|
|
|
Investment, interest rate, floor |
[9],[11],[13],[19],[21],[25] |
9.95%
|
|
|
|
9.95%
|
|
|
|
Investment, interest rate, cap |
[9],[11],[13],[19],[21],[25] |
10.70%
|
|
|
|
10.70%
|
|
|
|
Principal amount |
[9],[13],[19],[21],[25] |
$ 143,350
|
|
|
|
|
|
|
|
Investment cost |
[2],[9],[13],[19],[21],[25] |
143,226
|
|
|
|
|
|
|
|
Investments at Fair Value |
[9],[13],[19],[21],[25] |
$ 147,815
|
|
|
|
|
|
|
|
Investment exit fee |
[9],[11],[13],[19],[21],[25] |
5.78%
|
|
|
|
5.78%
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Axsome Therapeutics, Inc. Senior Secured, Maturity Date October 2026, Prime + 5.70%, Floor rate 8.95%, Cap rate 10.70%, 5.31% Exit Fee |
|
|
|
|
|
|
|
|
|
Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[10],[17],[23],[24],[27] |
|
|
2026-10
|
|
|
|
2026-10
|
|
Investment, basis spread, variable rate |
[10],[12],[17],[23],[24],[27] |
|
|
5.70%
|
|
|
|
5.70%
|
|
Investment, interest rate, floor |
[10],[12],[17],[23],[24],[27] |
|
|
8.95%
|
|
|
|
8.95%
|
|
Investment, interest rate, cap |
[10],[12],[17],[23],[24],[27] |
|
|
10.70%
|
|
|
|
10.70%
|
|
Principal amount |
[10],[17],[23],[24],[27] |
|
|
$ 81,725
|
|
|
|
|
|
Investment cost |
[6],[10],[17],[23],[24],[27] |
|
|
81,631
|
|
|
|
|
|
Investments at Fair Value |
[10],[17],[23],[24],[27] |
|
|
$ 78,074
|
|
|
|
|
|
Investment exit fee |
[10],[12],[17],[23],[24],[27] |
|
|
5.31%
|
|
|
|
5.31%
|
|
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Bicycle Therapeutics PLC, Senior Secured, Maturity Date July 2025, Prime + 4.55%, Floor rate 8.05%, Cap rate 9.05%, 5.00% Exit Fee |
|
|
|
|
|
|
|
|
|
Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2025-07
|
[13],[19],[25],[26] |
2025-07
|
[17],[23],[27],[28] |
2025-07
|
[13],[19],[25],[26] |
2025-07
|
[17],[23],[27],[28] |
Investment, basis spread, variable rate |
|
4.55%
|
[11],[13],[19],[25],[26] |
4.55%
|
[12],[17],[23],[27],[28] |
4.55%
|
[11],[13],[19],[25],[26] |
4.55%
|
[12],[17],[23],[27],[28] |
Investment, interest rate, floor |
|
8.05%
|
[11],[13],[19],[25],[26] |
8.05%
|
[12],[17],[23],[27],[28] |
8.05%
|
[11],[13],[19],[25],[26] |
8.05%
|
[12],[17],[23],[27],[28] |
Investment, interest rate, cap |
|
9.05%
|
[11],[13],[19],[25],[26] |
9.05%
|
[12],[17],[23],[27],[28] |
9.05%
|
[11],[13],[19],[25],[26] |
9.05%
|
[12],[17],[23],[27],[28] |
Principal amount |
|
$ 11,500
|
[13],[19],[25],[26] |
$ 11,500
|
[17],[23],[27],[28] |
|
|
|
|
Investment cost |
|
11,849
|
[2],[13],[19],[25],[26] |
11,757
|
[6],[17],[23],[27],[28] |
|
|
|
|
Investments at Fair Value |
|
$ 11,654
|
[13],[19],[25],[26] |
$ 11,435
|
[17],[23],[27],[28] |
|
|
|
|
Investment exit fee |
|
5.00%
|
[11],[13],[19],[25],[26] |
5.00%
|
[12],[17],[23],[27],[28] |
5.00%
|
[11],[13],[19],[25],[26] |
5.00%
|
[12],[17],[23],[27],[28] |
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and BiomX, INC, Senior Secured, Maturity Date September 2025, Prime + 5.70%, Floor rate 8.95%, 6.55% Exit Fee |
|
|
|
|
|
|
|
|
|
Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2025-09
|
[19],[25],[26] |
2025-09
|
[17],[27],[28] |
2025-09
|
[19],[25],[26] |
2025-09
|
[17],[27],[28] |
Investment, basis spread, variable rate |
|
5.70%
|
[11],[19],[25],[26] |
5.70%
|
[12],[17],[27],[28] |
5.70%
|
[11],[19],[25],[26] |
5.70%
|
[12],[17],[27],[28] |
Investment, interest rate, floor |
|
8.95%
|
[11],[19],[25],[26] |
8.95%
|
[12],[17],[27],[28] |
8.95%
|
[11],[19],[25],[26] |
8.95%
|
[12],[17],[27],[28] |
Principal amount |
|
$ 7,242
|
[19],[25],[26] |
$ 9,000
|
[17],[27],[28] |
|
|
|
|
Investment cost |
|
7,557
|
[2],[19],[25],[26] |
9,174
|
[6],[17],[27],[28] |
|
|
|
|
Investments at Fair Value |
|
$ 7,567
|
[19],[25],[26] |
$ 9,052
|
[17],[27],[28] |
|
|
|
|
Investment exit fee |
|
6.55%
|
[11],[19],[25],[26] |
6.55%
|
[12],[17],[27],[28] |
6.55%
|
[11],[19],[25],[26] |
6.55%
|
[12],[17],[27],[28] |
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Braeburn, Inc., Senior Secured, Maturity Date October2028, Prime + 2.45%, Floor rate 10.95%, PIK Interest 1.10%, 5.45% Exit Fee |
|
|
|
|
|
|
|
|
|
Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2028-10
|
|
|
|
2028-10
|
|
|
|
Investment, basis spread, variable rate |
[11] |
2.45%
|
|
|
|
2.45%
|
|
|
|
Investment, interest rate, floor |
[11] |
10.95%
|
|
|
|
10.95%
|
|
|
|
Investment, interest rate, paid in kind |
[11] |
1.10%
|
|
|
|
1.10%
|
|
|
|
Principal amount |
|
$ 52,500
|
|
|
|
|
|
|
|
Investment cost |
[2] |
51,942
|
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 51,942
|
|
|
|
|
|
|
|
Investment exit fee |
[11] |
5.45%
|
|
|
|
5.45%
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and BridgeBio Pharma, Inc. Senior Secured, Maturity Date November 2026, FIXED 9.00%, 2.00% Exit Fee |
|
|
|
|
|
|
|
|
|
Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2026-11
|
[7],[8],[13] |
2026-11
|
[16],[22],[23] |
2026-11
|
[7],[8],[13] |
2026-11
|
[16],[22],[23] |
Investment, interest rate, paid in cash |
|
9.00%
|
[7],[8],[11],[13] |
9.00%
|
[12],[16],[22],[23] |
9.00%
|
[7],[8],[11],[13] |
9.00%
|
[12],[16],[22],[23] |
Principal amount |
|
$ 38,167
|
[7],[8],[13] |
$ 37,312
|
[16],[22],[23] |
|
|
|
|
Investment cost |
|
38,064
|
[2],[7],[8],[13] |
37,039
|
[6],[16],[22],[23] |
|
|
|
|
Investments at Fair Value |
|
$ 34,821
|
[7],[8],[13] |
$ 33,344
|
[16],[22],[23] |
|
|
|
|
Investment exit fee |
|
2.00%
|
[7],[8],[11],[13] |
2.00%
|
[12],[16],[22],[23] |
2.00%
|
[7],[8],[11],[13] |
2.00%
|
[12],[16],[22],[23] |
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Cellarity, Inc. Senior Secured, Maturity Date June 2026, Prime + 5.70%, Floor rate 8.95%, 3.75% Exit Fee |
|
|
|
|
|
|
|
|
|
Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2026-06
|
[1],[8] |
2026-06
|
[22],[31] |
2026-06
|
[1],[8] |
2026-06
|
[22],[31] |
Investment, basis spread, variable rate |
|
5.70%
|
[1],[8],[11] |
5.70%
|
[12],[22],[31] |
5.70%
|
[1],[8],[11] |
5.70%
|
[12],[22],[31] |
Investment, interest rate, floor |
|
8.95%
|
[1],[8],[11] |
8.95%
|
[12],[22],[31] |
8.95%
|
[1],[8],[11] |
8.95%
|
[12],[22],[31] |
Principal amount |
|
$ 30,000
|
[1],[8] |
$ 30,000
|
[22],[31] |
|
|
|
|
Investment cost |
|
30,170
|
[1],[2],[8] |
29,841
|
[6],[22],[31] |
|
|
|
|
Investments at Fair Value |
|
$ 30,747
|
[1],[8] |
$ 30,097
|
[22],[31] |
|
|
|
|
Investment exit fee |
|
3.75%
|
[1],[8],[11] |
3.75%
|
[12],[22],[31] |
3.75%
|
[1],[8],[11] |
3.75%
|
[12],[22],[31] |
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Century Therapeutics, Inc. Senior Secured, Maturity Date April 2024, Prime + 6.30%, Floor rate 9.55%, 3.95% Exit Fee |
|
|
|
|
|
|
|
|
|
Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[17] |
|
|
2024-04
|
|
|
|
2024-04
|
|
Investment, basis spread, variable rate |
[12],[17] |
|
|
6.30%
|
|
|
|
6.30%
|
|
Investment, interest rate, floor |
[12],[17] |
|
|
9.55%
|
|
|
|
9.55%
|
|
Principal amount |
[17] |
|
|
$ 10,000
|
|
|
|
|
|
Investment cost |
[6],[17] |
|
|
10,235
|
|
|
|
|
|
Investments at Fair Value |
[17] |
|
|
$ 10,292
|
|
|
|
|
|
Investment exit fee |
[12],[17] |
|
|
3.95%
|
|
|
|
3.95%
|
|
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Codiak Biosciences, Inc. Senior Secured, Maturity Date October 2025, Prime + 5.00%, Floor rate 8.25%, 5.50% Exit Fee |
|
|
|
|
|
|
|
|
|
Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[17] |
|
|
2025-10
|
|
|
|
2025-10
|
|
Investment, basis spread, variable rate |
[12],[17] |
|
|
5.00%
|
|
|
|
5.00%
|
|
Investment, interest rate, floor |
[12],[17] |
|
|
8.25%
|
|
|
|
8.25%
|
|
Principal amount |
[17] |
|
|
$ 25,000
|
|
|
|
|
|
Investment cost |
[6],[17] |
|
|
25,759
|
|
|
|
|
|
Investments at Fair Value |
[17] |
|
|
$ 25,177
|
|
|
|
|
|
Investment exit fee |
[12],[17] |
|
|
5.50%
|
|
|
|
5.50%
|
|
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Compass Pathways plc Senior Secured, Maturity Date June 2026, Prime + 1.50%, Floor rate 9.75%, PIK Interest 1.40%, 4.75% Exit Fee |
|
|
|
|
|
|
|
|
|
Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[7],[25],[26] |
2027-07
|
|
|
|
2027-07
|
|
|
|
Investment, basis spread, variable rate |
[7],[11],[25],[26] |
1.50%
|
|
|
|
1.50%
|
|
|
|
Investment, interest rate, floor |
[7],[11],[25],[26] |
9.75%
|
|
|
|
9.75%
|
|
|
|
Investment, interest rate, paid in kind |
[7],[11],[25],[26] |
1.40%
|
|
|
|
1.40%
|
|
|
|
Principal amount |
[7],[25],[26] |
$ 24,059
|
|
|
|
|
|
|
|
Investment cost |
[2],[7],[25],[26] |
23,605
|
|
|
|
|
|
|
|
Investments at Fair Value |
[7],[25],[26] |
$ 23,605
|
|
|
|
|
|
|
|
Investment exit fee |
[7],[11],[25],[26] |
4.75%
|
|
|
|
4.75%
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Corium, Inc. Senior Secured, Maturity Date September 2026, Prime + 5.70%, Floor rate 8.95%, 7.75% Exit Fee |
|
|
|
|
|
|
|
|
|
Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2026-09
|
[8],[21] |
2026-09
|
[22],[24] |
2026-09
|
[8],[21] |
2026-09
|
[22],[24] |
Investment, basis spread, variable rate |
|
5.70%
|
[8],[11],[21] |
5.70%
|
[12],[22],[24] |
5.70%
|
[8],[11],[21] |
5.70%
|
[12],[22],[24] |
Investment, interest rate, floor |
|
8.95%
|
[8],[11],[21] |
8.95%
|
[12],[22],[24] |
8.95%
|
[8],[11],[21] |
8.95%
|
[12],[22],[24] |
Principal amount |
|
$ 132,675
|
[8],[21] |
$ 132,675
|
[22],[24] |
|
|
|
|
Investment cost |
|
135,071
|
[2],[8],[21] |
133,557
|
[6],[22],[24] |
|
|
|
|
Investments at Fair Value |
|
$ 137,809
|
[8],[21] |
$ 135,619
|
[22],[24] |
|
|
|
|
Investment exit fee |
|
7.75%
|
[8],[11],[21] |
7.75%
|
[12],[22],[24] |
7.75%
|
[8],[11],[21] |
7.75%
|
[12],[22],[24] |
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Curevo, Inc. Senior Secured, Maturity Date June 2027 Prime + 1.70%, Floor rate 9.70%, 6.95% Exit Fee |
|
|
|
|
|
|
|
|
|
Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[1] |
2027-06
|
|
|
|
2027-06
|
|
|
|
Investment, basis spread, variable rate |
[1],[11] |
1.70%
|
|
|
|
1.70%
|
|
|
|
Investment, interest rate, floor |
[1],[11] |
9.70%
|
|
|
|
9.70%
|
|
|
|
Principal amount |
[1] |
$ 10,000
|
|
|
|
|
|
|
|
Investment cost |
[1],[2] |
9,746
|
|
|
|
|
|
|
|
Investments at Fair Value |
[1] |
$ 9,746
|
|
|
|
|
|
|
|
Investment exit fee |
[1],[11] |
6.95%
|
|
|
|
6.95%
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Eloxx Pharmaceuticals, Inc. Senior Secured, Maturity Date April 2025, Prime + 6.25%, Floor rate 9.50%, 6.55% Exit Fee |
|
|
|
|
|
|
|
|
|
Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2025-04
|
[1] |
2025-04
|
[31] |
2025-04
|
[1] |
2025-04
|
[31] |
Investment, basis spread, variable rate |
|
6.25%
|
[1],[11] |
6.25%
|
[12],[31] |
6.25%
|
[1],[11] |
6.25%
|
[12],[31] |
Investment, interest rate, floor |
|
9.50%
|
[1],[11] |
9.50%
|
[12],[31] |
9.50%
|
[1],[11] |
9.50%
|
[12],[31] |
Principal amount |
|
$ 4,780
|
[1] |
$ 12,500
|
[31] |
|
|
|
|
Investment cost |
|
5,444
|
[1],[2] |
12,753
|
[6],[31] |
|
|
|
|
Investments at Fair Value |
|
$ 5,337
|
[1] |
$ 12,535
|
[31] |
|
|
|
|
Investment exit fee |
|
6.55%
|
[1],[11] |
6.55%
|
[12],[31] |
6.55%
|
[1],[11] |
6.55%
|
[12],[31] |
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Finch Therapeutics Group, Inc. Senior Secured, Maturity Date November 2026, Prime + 4.05%, Floor rate 7.55%, Cap rate 8.80%, 5.50% Exit Fee |
|
|
|
|
|
|
|
|
|
Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
|
|
|
2026-11
|
|
|
|
2026-11
|
|
Investment, basis spread, variable rate |
[12] |
|
|
4.05%
|
|
|
|
4.05%
|
|
Investment, interest rate, floor |
[12] |
|
|
7.55%
|
|
|
|
7.55%
|
|
Investment, interest rate, cap |
[12] |
|
|
8.80%
|
|
|
|
8.80%
|
|
Principal amount |
|
|
|
$ 15,000
|
|
|
|
|
|
Investment cost |
[6] |
|
|
15,012
|
|
|
|
|
|
Investments at Fair Value |
|
|
|
$ 13,940
|
|
|
|
|
|
Investment exit fee |
[12] |
|
|
5.50%
|
|
|
|
5.50%
|
|
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and G1 Therapeutics, Inc. Senior Secured, Maturity Date November 2026, Prime + 5.65%, Floor rate 9.15%, 11.41% Exit Fee |
|
|
|
|
|
|
|
|
|
Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[1],[13],[19] |
2026-11
|
|
|
|
2026-11
|
|
|
|
Investment, basis spread, variable rate |
[1],[11],[13],[19] |
5.65%
|
|
|
|
5.65%
|
|
|
|
Investment, interest rate, floor |
[1],[11],[13],[19] |
9.15%
|
|
|
|
9.15%
|
|
|
|
Principal amount |
[1],[13],[19] |
$ 38,750
|
|
|
|
|
|
|
|
Investment cost |
[1],[2],[13],[19] |
39,530
|
|
|
|
|
|
|
|
Investments at Fair Value |
[1],[13],[19] |
$ 40,014
|
|
|
|
|
|
|
|
Investment exit fee |
[1],[11],[13],[19] |
11.41%
|
|
|
|
11.41%
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and G1 Therapeutics, Inc. Senior Secured, Maturity Date November 2026, Prime + 5.90%, Floor rate 9.15%, 9.86% Exit Fee |
|
|
|
|
|
|
|
|
|
Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[10],[17],[23],[31] |
|
|
2026-11
|
|
|
|
2026-11
|
|
Investment, basis spread, variable rate |
[10],[12],[17],[23],[31] |
|
|
5.90%
|
|
|
|
5.90%
|
|
Investment, interest rate, floor |
[10],[12],[17],[23],[31] |
|
|
9.15%
|
|
|
|
9.15%
|
|
Principal amount |
[10],[17],[23],[31] |
|
|
$ 58,125
|
|
|
|
|
|
Investment cost |
[6],[10],[17],[23],[31] |
|
|
58,674
|
|
|
|
|
|
Investments at Fair Value |
[10],[17],[23],[31] |
|
|
$ 58,407
|
|
|
|
|
|
Investment exit fee |
[10],[12],[17],[23],[31] |
|
|
9.86%
|
|
|
|
9.86%
|
|
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Geron Corporation, Senior Secured, Maturity Date April 2025, Prime + 5.75%, Floor rate 9.00%, 6.55% Exit Fee |
|
|
|
|
|
|
|
|
|
Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[8],[9],[13],[25] |
2025-04
|
|
|
|
2025-04
|
|
|
|
Investment, basis spread, variable rate |
[8],[9],[11],[13],[25] |
5.75%
|
|
|
|
5.75%
|
|
|
|
Investment, interest rate, floor |
[8],[9],[11],[13],[25] |
9.00%
|
|
|
|
9.00%
|
|
|
|
Principal amount |
[8],[9],[13],[25] |
$ 18,500
|
|
|
|
|
|
|
|
Investment cost |
[2],[8],[9],[13],[25] |
19,314
|
|
|
|
|
|
|
|
Investments at Fair Value |
[8],[9],[13],[25] |
$ 19,603
|
|
|
|
|
|
|
|
Investment exit fee |
[8],[9],[11],[13],[25] |
6.55%
|
|
|
|
6.55%
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Geron Corporation, Senior Secured, Maturity Date October 2024, Prime + 5.75%, Floor rate 9.00%, 6.55% Exit Fee |
|
|
|
|
|
|
|
|
|
Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[22],[23],[27] |
|
|
2024-10
|
|
|
|
2024-10
|
|
Investment, basis spread, variable rate |
[12],[22],[23],[27] |
|
|
5.75%
|
|
|
|
5.75%
|
|
Investment, interest rate, floor |
[12],[22],[23],[27] |
|
|
9.00%
|
|
|
|
9.00%
|
|
Principal amount |
[22],[23],[27] |
|
|
$ 18,500
|
|
|
|
|
|
Investment cost |
[6],[22],[23],[27] |
|
|
19,109
|
|
|
|
|
|
Investments at Fair Value |
[22],[23],[27] |
|
|
$ 19,174
|
|
|
|
|
|
Investment exit fee |
[12],[22],[23],[27] |
|
|
6.55%
|
|
|
|
6.55%
|
|
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Gritstone Bio, Inc. Senior Secured, Maturity Date July 2027, Prime + 3.15%, Floor rate 7.15%, Cap rate 8.65%, PIK Interest 2.00%, 5.75% Exit Fee |
|
|
|
|
|
|
|
|
|
Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2027-07
|
[7],[8],[9] |
2027-07
|
[10],[16] |
2027-07
|
[7],[8],[9] |
2027-07
|
[10],[16] |
Investment, basis spread, variable rate |
|
3.15%
|
[7],[8],[9],[11] |
3.15%
|
[10],[12],[16] |
3.15%
|
[7],[8],[9],[11] |
3.15%
|
[10],[12],[16] |
Investment, interest rate, floor |
|
7.15%
|
[7],[8],[9],[11] |
7.15%
|
[10],[12],[16] |
7.15%
|
[7],[8],[9],[11] |
7.15%
|
[10],[12],[16] |
Investment, interest rate, cap |
|
8.65%
|
[7],[8],[9],[11] |
8.65%
|
[10],[12],[16] |
8.65%
|
[7],[8],[9],[11] |
8.65%
|
[10],[12],[16] |
Investment, interest rate, paid in kind |
|
2.00%
|
[7],[8],[9],[11] |
2.00%
|
[10],[12],[16] |
2.00%
|
[7],[8],[9],[11] |
2.00%
|
[10],[12],[16] |
Principal amount |
|
$ 22,916
|
[7],[8],[9] |
$ 15,113
|
[10],[16] |
|
|
|
|
Investment cost |
|
23,062
|
[2],[7],[8],[9] |
15,109
|
[6],[10],[16] |
|
|
|
|
Investments at Fair Value |
|
$ 23,118
|
[7],[8],[9] |
$ 15,109
|
[10],[16] |
|
|
|
|
Investment exit fee |
|
5.75%
|
[7],[8],[9],[11] |
5.75%
|
[10],[12],[16] |
5.75%
|
[7],[8],[9],[11] |
5.75%
|
[10],[12],[16] |
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Heron Therapeutics, Inc.. Senior Secured, Maturity Date February 2026, Prime + 1.70%, Floor rate 9.95%, PIK Interest 1.50%, 3.00% Exit Fee |
|
|
|
|
|
|
|
|
|
Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[1],[7] |
2026-02
|
|
|
|
2026-02
|
|
|
|
Investment, basis spread, variable rate |
[1],[7],[11] |
1.70%
|
|
|
|
1.70%
|
|
|
|
Investment, interest rate, floor |
[1],[7],[11] |
9.95%
|
|
|
|
9.95%
|
|
|
|
Investment, interest rate, paid in kind |
[1],[7],[11] |
1.50%
|
|
|
|
1.50%
|
|
|
|
Principal amount |
[1],[7] |
$ 20,019
|
|
|
|
|
|
|
|
Investment cost |
[1],[2],[7] |
19,624
|
|
|
|
|
|
|
|
Investments at Fair Value |
[1],[7] |
$ 19,624
|
|
|
|
|
|
|
|
Investment exit fee |
[1],[7],[11] |
3.00%
|
|
|
|
3.00%
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Hibercell, Inc. Senior Secured, Maturity Date May 2025, Prime + 5.40%, Floor rate 8.65%, 4.95% Exit Fee |
|
|
|
|
|
|
|
|
|
Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2025-05
|
[1],[8] |
2025-05
|
[22],[31] |
2025-05
|
[1],[8] |
2025-05
|
[22],[31] |
Investment, basis spread, variable rate |
|
5.40%
|
[1],[8],[11] |
5.40%
|
[12],[22],[31] |
5.40%
|
[1],[8],[11] |
5.40%
|
[12],[22],[31] |
Investment, interest rate, floor |
|
8.65%
|
[1],[8],[11] |
8.65%
|
[12],[22],[31] |
8.65%
|
[1],[8],[11] |
8.65%
|
[12],[22],[31] |
Principal amount |
|
$ 14,495
|
[1],[8] |
$ 17,000
|
[22],[31] |
|
|
|
|
Investment cost |
|
15,014
|
[1],[2],[8] |
17,313
|
[6],[22],[31] |
|
|
|
|
Investments at Fair Value |
|
$ 15,047
|
[1],[8] |
$ 17,265
|
[22],[31] |
|
|
|
|
Investment exit fee |
|
4.95%
|
[1],[8],[11] |
4.95%
|
[12],[22],[31] |
4.95%
|
[1],[8],[11] |
4.95%
|
[12],[22],[31] |
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and HilleVax, Inc. Senior Secured, Maturity Date May 2027, Prime + 1.05%, Floor rate 4.55%, Cap rate 6.05%, PIK Interest 2.85%, 7.15% Exit Fee |
|
|
|
|
|
|
|
|
|
Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2027-05
|
[1],[7] |
2027-05
|
[10],[16],[31] |
2027-05
|
[1],[7] |
2027-05
|
[10],[16],[31] |
Investment, basis spread, variable rate |
|
1.05%
|
[1],[7],[11] |
1.05%
|
[10],[12],[16],[31] |
1.05%
|
[1],[7],[11] |
1.05%
|
[10],[12],[16],[31] |
Investment, interest rate, floor |
|
4.55%
|
[1],[7],[11] |
4.55%
|
[10],[12],[16],[31] |
4.55%
|
[1],[7],[11] |
4.55%
|
[10],[12],[16],[31] |
Investment, interest rate, cap |
|
6.05%
|
[1],[7],[11] |
6.05%
|
[10],[12],[16],[31] |
6.05%
|
[1],[7],[11] |
6.05%
|
[10],[12],[16],[31] |
Investment, interest rate, paid in kind |
|
2.85%
|
[1],[7],[11] |
2.85%
|
[10],[12],[16],[31] |
2.85%
|
[1],[7],[11] |
2.85%
|
[10],[12],[16],[31] |
Principal amount |
|
$ 20,377
|
[1],[7] |
$ 12,072
|
[10],[16],[31] |
|
|
|
|
Investment cost |
|
20,441
|
[1],[2],[7] |
12,043
|
[6],[10],[16],[31] |
|
|
|
|
Investments at Fair Value |
|
$ 19,828
|
[1],[7] |
$ 11,333
|
[10],[16],[31] |
|
|
|
|
Investment exit fee |
|
7.15%
|
[1],[7],[11] |
7.15%
|
[10],[12],[16],[31] |
7.15%
|
[1],[7],[11] |
7.15%
|
[10],[12],[16],[31] |
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Iveric Bio, Inc. Senior Secured, Maturity Date August 2027, Prime + 4.00%, Floor rate 8.75%, Cap rate 10.25%, 4.25% Exit Fee |
|
|
|
|
|
|
|
|
|
Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[23],[27] |
|
|
2027-08
|
|
|
|
2027-08
|
|
Investment, basis spread, variable rate |
[12],[23],[27] |
|
|
4.00%
|
|
|
|
4.00%
|
|
Investment, interest rate, floor |
[12],[23],[27] |
|
|
8.75%
|
|
|
|
8.75%
|
|
Investment, interest rate, cap |
[12],[23],[27] |
|
|
10.25%
|
|
|
|
10.25%
|
|
Principal amount |
[23],[27] |
|
|
$ 49,500
|
|
|
|
|
|
Investment cost |
[6],[23],[27] |
|
|
49,090
|
|
|
|
|
|
Investments at Fair Value |
[23],[27] |
|
|
$ 49,090
|
|
|
|
|
|
Investment exit fee |
[12],[23],[27] |
|
|
4.25%
|
|
|
|
4.25%
|
|
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Kura Oncology, Inc. Senior Secured, Maturity Date November 2027, Prime + 2.40%, Floor rate 8.65%, 15.13% Exit Fee |
|
|
|
|
|
|
|
|
|
Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2027-11
|
[1],[25] |
2027-11
|
[10],[27],[31] |
2027-11
|
[1],[25] |
2027-11
|
[10],[27],[31] |
Investment, basis spread, variable rate |
|
2.40%
|
[1],[11],[25] |
2.40%
|
[10],[12],[27],[31] |
2.40%
|
[1],[11],[25] |
2.40%
|
[10],[12],[27],[31] |
Investment, interest rate, floor |
|
8.65%
|
[1],[11],[25] |
8.65%
|
[10],[12],[27],[31] |
8.65%
|
[1],[11],[25] |
8.65%
|
[10],[12],[27],[31] |
Principal amount |
|
$ 5,500
|
[1],[25] |
$ 5,500
|
[10],[27],[31] |
|
|
|
|
Investment cost |
|
5,510
|
[1],[2],[25] |
5,448
|
[6],[10],[27],[31] |
|
|
|
|
Investments at Fair Value |
|
$ 5,687
|
[1],[25] |
$ 5,448
|
[10],[27],[31] |
|
|
|
|
Investment exit fee |
|
15.13%
|
[1],[11],[25] |
15.13%
|
[10],[12],[27],[31] |
15.13%
|
[1],[11],[25] |
15.13%
|
[10],[12],[27],[31] |
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Locus Biosciences, Inc. Senior Secured, Maturity Date July 2025, Prime + 6.10%, Floor rate 9.35%, 4.95% Exit Fee |
|
|
|
|
|
|
|
|
|
Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2025-07
|
[1] |
2025-07
|
[31] |
2025-07
|
[1] |
2025-07
|
[31] |
Investment, basis spread, variable rate |
|
6.10%
|
[1],[11] |
6.10%
|
[12],[31] |
6.10%
|
[1],[11] |
6.10%
|
[12],[31] |
Investment, interest rate, floor |
|
9.35%
|
[1],[11] |
9.35%
|
[12],[31] |
9.35%
|
[1],[11] |
9.35%
|
[12],[31] |
Principal amount |
|
$ 6,140
|
[1] |
$ 8,000
|
[31] |
|
|
|
|
Investment cost |
|
6,361
|
[1],[2] |
8,120
|
[6],[31] |
|
|
|
|
Investments at Fair Value |
|
$ 6,394
|
[1] |
$ 8,085
|
[31] |
|
|
|
|
Investment exit fee |
|
4.95%
|
[1],[11] |
4.95%
|
[12],[31] |
4.95%
|
[1],[11] |
4.95%
|
[12],[31] |
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Madrigal Pharmaceutical, Inc. Senior Secured, Maturity Date May 2026, Prime + 2.45%, Floor rate 8.25%, 5.35% Exit Fee |
|
|
|
|
|
|
|
|
|
Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[25] |
2026-05
|
|
|
|
2026-05
|
|
|
|
Investment, basis spread, variable rate |
[11],[25] |
2.45%
|
|
|
|
2.45%
|
|
|
|
Investment, interest rate, floor |
[11],[25] |
8.25%
|
|
|
|
8.25%
|
|
|
|
Principal amount |
[25] |
$ 78,200
|
|
|
|
|
|
|
|
Investment cost |
[2],[25] |
78,324
|
|
|
|
|
|
|
|
Investments at Fair Value |
[25] |
$ 80,521
|
|
|
|
|
|
|
|
Investment exit fee |
[11],[25] |
5.35%
|
|
|
|
5.35%
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Madrigal Pharmaceutical, Inc. Senior Secured, Maturity Date May 2026, Prime + 3.95%, Floor rate 7.45%, 5.35% Exit Fee |
|
|
|
|
|
|
|
|
|
Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[10],[27] |
|
|
2026-05
|
|
|
|
2026-05
|
|
Investment, basis spread, variable rate |
[10],[12],[27] |
|
|
3.95%
|
|
|
|
3.95%
|
|
Investment, interest rate, floor |
[10],[12],[27] |
|
|
7.45%
|
|
|
|
7.45%
|
|
Principal amount |
[10],[27] |
|
|
$ 34,000
|
|
|
|
|
|
Investment cost |
[6],[10],[27] |
|
|
33,945
|
|
|
|
|
|
Investments at Fair Value |
[10],[27] |
|
|
$ 33,987
|
|
|
|
|
|
Investment exit fee |
[10],[12],[27] |
|
|
5.35%
|
|
|
|
5.35%
|
|
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Nabriva Therapeutics, Senior Secured, Maturity Date June 2023, Prime + 4.30%, Floor rate 9.80%, 9.95% Exit Fee |
|
|
|
|
|
|
|
|
|
Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[22],[27],[28] |
|
|
2023-06
|
|
|
|
2023-06
|
|
Investment, basis spread, variable rate |
[12],[22],[27],[28] |
|
|
4.30%
|
|
|
|
4.30%
|
|
Investment, interest rate, floor |
[12],[22],[27],[28] |
|
|
9.80%
|
|
|
|
9.80%
|
|
Principal amount |
[22],[27],[28] |
|
|
$ 2,079
|
|
|
|
|
|
Investment cost |
[6],[22],[27],[28] |
|
|
2,734
|
|
|
|
|
|
Investments at Fair Value |
[22],[27],[28] |
|
|
$ 2,804
|
|
|
|
|
|
Investment exit fee |
[12],[22],[27],[28] |
|
|
9.95%
|
|
|
|
9.95%
|
|
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Phathom Pharmaceuticals, Inc. Senior Secured, Maturity Date October 2026, Prime + 2.25%, Floor rate 5.50%, PIK Interest 3.35%, 7.50% Exit Fee |
|
|
|
|
|
|
|
|
|
Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2026-10
|
[1],[7],[9],[13],[21],[25],[38] |
2026-10
|
[10],[16],[23],[24],[27],[31],[39] |
2026-10
|
[1],[7],[9],[13],[21],[25],[38] |
2026-10
|
[10],[16],[23],[24],[27],[31],[39] |
Investment, basis spread, variable rate |
|
2.25%
|
[1],[7],[9],[11],[13],[21],[25],[38] |
2.25%
|
[10],[12],[16],[23],[24],[27],[31],[39] |
2.25%
|
[1],[7],[9],[11],[13],[21],[25],[38] |
2.25%
|
[10],[12],[16],[23],[24],[27],[31],[39] |
Investment, interest rate, floor |
|
5.50%
|
[1],[7],[9],[11],[13],[21],[25],[38] |
5.50%
|
[10],[12],[16],[23],[24],[27],[31],[39] |
5.50%
|
[1],[7],[9],[11],[13],[21],[25],[38] |
5.50%
|
[10],[12],[16],[23],[24],[27],[31],[39] |
Investment, interest rate, paid in kind |
|
3.35%
|
[1],[7],[9],[11],[13],[21],[25],[38] |
3.35%
|
[10],[12],[16],[23],[24],[27],[31],[39] |
3.35%
|
[1],[7],[9],[11],[13],[21],[25],[38] |
3.35%
|
[10],[12],[16],[23],[24],[27],[31],[39] |
Principal amount |
|
$ 97,049
|
[1],[7],[9],[13],[21],[25],[38] |
$ 94,737
|
[10],[16],[23],[24],[27],[31],[39] |
|
|
|
|
Investment cost |
|
98,323
|
[1],[2],[7],[9],[13],[21],[25],[38] |
95,032
|
[6],[10],[16],[23],[24],[27],[31],[39] |
|
|
|
|
Investments at Fair Value |
|
$ 99,188
|
[1],[7],[9],[13],[21],[25],[38] |
$ 93,916
|
[10],[16],[23],[24],[27],[31],[39] |
|
|
|
|
Investment exit fee |
|
7.50%
|
[1],[7],[9],[11],[13],[21],[25],[38] |
7.50%
|
[10],[12],[16],[23],[24],[27],[31],[39] |
7.50%
|
[1],[7],[9],[11],[13],[21],[25],[38] |
7.50%
|
[10],[12],[16],[23],[24],[27],[31],[39] |
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Provention Bio, Inc. Senior Secured, Maturity Date September 2027, Prime + 2.70%, Floor rate 8.20%, 6.60% Exit Fee |
|
|
|
|
|
|
|
|
|
Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[10] |
|
|
2027-09
|
|
|
|
2027-09
|
|
Investment, basis spread, variable rate |
[10],[12] |
|
|
2.70%
|
|
|
|
2.70%
|
|
Investment, interest rate, floor |
[10],[12] |
|
|
8.20%
|
|
|
|
8.20%
|
|
Principal amount |
[10] |
|
|
$ 25,000
|
|
|
|
|
|
Investment cost |
[6],[10] |
|
|
24,670
|
|
|
|
|
|
Investments at Fair Value |
[10] |
|
|
$ 24,670
|
|
|
|
|
|
Investment exit fee |
[10],[12] |
|
|
6.60%
|
|
|
|
6.60%
|
|
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Redshift Bioanalytics, Inc. Senior Secured, Maturity Date January 2026, Prime + 4.25%, Floor rate 7.50%, 3.80% Exit Fee |
|
|
|
|
|
|
|
|
|
Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[1] |
2026-01
|
|
2026-01
|
|
2026-01
|
|
2026-01
|
|
Investment, basis spread, variable rate |
[1] |
4.25%
|
[11] |
4.25%
|
[12] |
4.25%
|
[11] |
4.25%
|
[12] |
Investment, interest rate, floor |
[1] |
7.50%
|
[11] |
7.50%
|
[12] |
7.50%
|
[11] |
7.50%
|
[12] |
Principal amount |
[1] |
$ 5,000
|
|
$ 5,000
|
|
|
|
|
|
Investment cost |
[1] |
5,024
|
[2] |
4,957
|
[6] |
|
|
|
|
Investments at Fair Value |
[1] |
$ 5,080
|
|
$ 4,946
|
|
|
|
|
|
Investment exit fee |
[1] |
3.80%
|
[11] |
3.80%
|
[12] |
3.80%
|
[11] |
3.80%
|
[12] |
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Replimune Group, Inc. Senior Secured, Maturity Date October 2027, Prime + 1.75%, Floor rate 7.25%, Cap rate 9.00%, PIK Interest 1.50%, 4.95% Exit Fee |
|
|
|
|
|
|
|
|
|
Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2027-10
|
[7],[13],[25] |
2027-10
|
[10],[16],[27] |
2027-10
|
[7],[13],[25] |
2027-10
|
[10],[16],[27] |
Investment, basis spread, variable rate |
|
1.75%
|
[7],[11],[13],[25] |
1.75%
|
[10],[12],[16],[27] |
1.75%
|
[7],[11],[13],[25] |
1.75%
|
[10],[12],[16],[27] |
Investment, interest rate, floor |
|
7.25%
|
[7],[11],[13],[25] |
7.25%
|
[10],[12],[16],[27] |
7.25%
|
[7],[11],[13],[25] |
7.25%
|
[10],[12],[16],[27] |
Investment, interest rate, cap |
|
9.00%
|
[7],[11],[13],[25] |
9.00%
|
[10],[12],[16],[27] |
9.00%
|
[7],[11],[13],[25] |
9.00%
|
[10],[12],[16],[27] |
Investment, interest rate, paid in kind |
|
1.50%
|
[7],[11],[13],[25] |
1.50%
|
[10],[12],[16],[27] |
1.50%
|
[7],[11],[13],[25] |
1.50%
|
[10],[12],[16],[27] |
Principal amount |
|
$ 20,986
|
[7],[13],[25] |
$ 20,754
|
[10],[16],[27] |
|
|
|
|
Investment cost |
|
21,035
|
[2],[7],[13],[25] |
20,656
|
[6],[10],[16],[27] |
|
|
|
|
Investments at Fair Value |
|
$ 21,536
|
[7],[13],[25] |
$ 20,656
|
[10],[16],[27] |
|
|
|
|
Investment exit fee |
|
4.95%
|
[7],[11],[13],[25] |
4.95%
|
[10],[12],[16],[27] |
4.95%
|
[7],[11],[13],[25] |
4.95%
|
[10],[12],[16],[27] |
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Scynexis, Inc. Senior Secured, Maturity Date March 2025, Prime + 5.80%, Floor rate 9.05%, 3.95% Exit Fee |
|
|
|
|
|
|
|
|
|
Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[22],[23] |
|
|
2025-03
|
|
|
|
2025-03
|
|
Investment, basis spread, variable rate |
[12],[22],[23] |
|
|
5.80%
|
|
|
|
5.80%
|
|
Investment, interest rate, floor |
[12],[22],[23] |
|
|
9.05%
|
|
|
|
9.05%
|
|
Principal amount |
[22],[23] |
|
|
$ 18,667
|
|
|
|
|
|
Investment cost |
[6],[22],[23] |
|
|
18,675
|
|
|
|
|
|
Investments at Fair Value |
[22],[23] |
|
|
$ 18,698
|
|
|
|
|
|
Investment exit fee |
[12],[22],[23] |
|
|
3.95%
|
|
|
|
3.95%
|
|
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Seres Therapeutics, Inc. Senior Secured, Maturity Date October 2024, Prime + 6.40%, Floor rate 9.65%, 4.98% Exit Fee |
|
|
|
|
|
|
|
|
|
Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[22],[23] |
|
|
2024-10
|
|
|
|
2024-10
|
|
Investment, basis spread, variable rate |
[12],[22],[23] |
|
|
6.40%
|
|
|
|
6.40%
|
|
Investment, interest rate, floor |
[12],[22],[23] |
|
|
9.65%
|
|
|
|
9.65%
|
|
Principal amount |
[22],[23] |
|
|
$ 37,500
|
|
|
|
|
|
Investment cost |
[6],[22],[23] |
|
|
38,638
|
|
|
|
|
|
Investments at Fair Value |
[22],[23] |
|
|
$ 38,816
|
|
|
|
|
|
Investment exit fee |
[12],[22],[23] |
|
|
4.98%
|
|
|
|
4.98%
|
|
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and TG Therapeutics, Inc. Senior Secured, Maturity Date January 2026, Prime + 1.20%, Floor rate 8.95%, PIK Interest 2.25%, 5.69% Exit Fee |
|
|
|
|
|
|
|
|
|
Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[7],[13],[19],[25] |
2026-01
|
|
|
|
2026-01
|
|
|
|
Investment, basis spread, variable rate |
[7],[11],[13],[19],[25] |
1.20%
|
|
|
|
1.20%
|
|
|
|
Investment, interest rate, floor |
[7],[11],[13],[19],[25] |
8.95%
|
|
|
|
8.95%
|
|
|
|
Investment, interest rate, paid in kind |
[7],[11],[13],[19],[25] |
2.25%
|
|
|
|
2.25%
|
|
|
|
Principal amount |
[7],[13],[19],[25] |
$ 65,398
|
|
|
|
|
|
|
|
Investment cost |
[2],[7],[13],[19],[25] |
65,737
|
|
|
|
|
|
|
|
Investments at Fair Value |
[7],[13],[19],[25] |
$ 66,736
|
|
|
|
|
|
|
|
Investment exit fee |
[7],[11],[13],[19],[25] |
5.69%
|
|
|
|
5.69%
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and TG Therapeutics, Inc. Senior Secured, Maturity Date January 2026, Prime + 2.15%, Floor rate 5.40%, PIK Interest 3.45%, 5.95% Exit Fee |
|
|
|
|
|
|
|
|
|
Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[16],[17],[23],[27] |
|
|
2026-01
|
|
|
|
2026-01
|
|
Investment, basis spread, variable rate |
[12],[16],[17],[23],[27] |
|
|
2.15%
|
|
|
|
2.15%
|
|
Investment, interest rate, floor |
[12],[16],[17],[23],[27] |
|
|
5.40%
|
|
|
|
5.40%
|
|
Investment, interest rate, paid in kind |
[12],[16],[17],[23],[27] |
|
|
3.45%
|
|
|
|
3.45%
|
|
Principal amount |
[16],[17],[23],[27] |
|
|
$ 47,983
|
|
|
|
|
|
Investment cost |
[6],[16],[17],[23],[27] |
|
|
47,889
|
|
|
|
|
|
Investments at Fair Value |
[16],[17],[23],[27] |
|
|
$ 48,649
|
|
|
|
|
|
Investment exit fee |
[12],[16],[17],[23],[27] |
|
|
5.95%
|
|
|
|
5.95%
|
|
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Tarsus Pharmaceuticals, Inc. Senior Secured, Maturity Date February 2027, Prime + 4.45%, Floor rate 8.45%, Cap rate 11.45%, 4.75% Exit Fee |
|
|
|
|
|
|
|
|
|
Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[8],[9],[25] |
2027-02
|
|
|
|
2027-02
|
|
|
|
Investment, basis spread, variable rate |
[8],[9],[11],[25] |
4.45%
|
|
|
|
4.45%
|
|
|
|
Investment, interest rate, floor |
[8],[9],[11],[25] |
8.45%
|
|
|
|
8.45%
|
|
|
|
Investment, interest rate, cap |
[8],[9],[11],[25] |
11.45%
|
|
|
|
11.45%
|
|
|
|
Principal amount |
[8],[9],[25] |
$ 12,375
|
|
|
|
|
|
|
|
Investment cost |
[2],[8],[9],[25] |
12,452
|
|
|
|
|
|
|
|
Investments at Fair Value |
[8],[9],[25] |
$ 12,701
|
|
|
|
|
|
|
|
Investment exit fee |
[8],[9],[11],[25] |
4.75%
|
|
|
|
4.75%
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Tarsus Pharmaceuticals, Inc. Senior Secured, Maturity Date February 2027, Prime + 5.20%, Floor rate 8.45%, 4.75% Exit Fee |
|
|
|
|
|
|
|
|
|
Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[10],[22],[27] |
|
|
2027-02
|
|
|
|
2027-02
|
|
Investment, basis spread, variable rate |
[10],[12],[22],[27] |
|
|
5.20%
|
|
|
|
5.20%
|
|
Investment, interest rate, floor |
[10],[12],[22],[27] |
|
|
8.45%
|
|
|
|
8.45%
|
|
Principal amount |
[10],[22],[27] |
|
|
$ 8,250
|
|
|
|
|
|
Investment cost |
[6],[10],[22],[27] |
|
|
8,274
|
|
|
|
|
|
Investments at Fair Value |
[10],[22],[27] |
|
|
$ 8,423
|
|
|
|
|
|
Investment exit fee |
[10],[12],[22],[27] |
|
|
4.75%
|
|
|
|
4.75%
|
|
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Unity Biotechnology, Inc. Senior Secured, Maturity Date August 2024, Prime + 6.10%, Floor rate 9.35%, 6.25% Exit Fee |
|
|
|
|
|
|
|
|
|
Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[22] |
|
|
2024-08
|
|
|
|
2024-08
|
|
Investment, basis spread, variable rate |
[12],[22] |
|
|
6.10%
|
|
|
|
6.10%
|
|
Investment, interest rate, floor |
[12],[22] |
|
|
9.35%
|
|
|
|
9.35%
|
|
Principal amount |
[22] |
|
|
$ 20,000
|
|
|
|
|
|
Investment cost |
[6],[22] |
|
|
21,079
|
|
|
|
|
|
Investments at Fair Value |
[22] |
|
|
$ 20,967
|
|
|
|
|
|
Investment exit fee |
[12],[22] |
|
|
6.25%
|
|
|
|
6.25%
|
|
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Valo Health, LLC, Senior Secured, Maturity Date May 2024, Prime + 6.45%, Floor rate 9.70%, 3.85% Exit Fee |
|
|
|
|
|
|
|
|
|
Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2024-05
|
[8],[19] |
2024-05
|
[17],[22] |
2024-05
|
[8],[19] |
2024-05
|
[17],[22] |
Investment, basis spread, variable rate |
|
6.45%
|
[8],[11],[19] |
6.45%
|
[12],[17],[22] |
6.45%
|
[8],[11],[19] |
6.45%
|
[12],[17],[22] |
Investment, interest rate, floor |
|
9.70%
|
[8],[11],[19] |
9.70%
|
[12],[17],[22] |
9.70%
|
[8],[11],[19] |
9.70%
|
[12],[17],[22] |
Principal amount |
|
$ 3,833
|
[8],[19] |
$ 8,146
|
[17],[22] |
|
|
|
|
Investment cost |
|
4,217
|
[2],[8],[19] |
8,416
|
[6],[17],[22] |
|
|
|
|
Investments at Fair Value |
|
$ 4,217
|
[8],[19] |
$ 8,410
|
[17],[22] |
|
|
|
|
Investment exit fee |
|
3.85%
|
[8],[11],[19] |
3.85%
|
[12],[17],[22] |
3.85%
|
[8],[11],[19] |
3.85%
|
[12],[17],[22] |
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Viridian Therapeutics, Inc. Senior Secured, Maturity Date October 2026, Prime + 4.20%, Floor rate 7.45%, Cap rate 8.95%, 4.76% Exit Fee |
|
|
|
|
|
|
|
|
|
Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[10],[22],[27] |
|
|
2026-10
|
|
|
|
2026-10
|
|
Investment, basis spread, variable rate |
[10],[12],[22],[27] |
|
|
4.20%
|
|
|
|
4.20%
|
|
Investment, interest rate, floor |
[10],[12],[22],[27] |
|
|
7.45%
|
|
|
|
7.45%
|
|
Investment, interest rate, cap |
[10],[12],[22],[27] |
|
|
8.95%
|
|
|
|
8.95%
|
|
Principal amount |
[10],[22],[27] |
|
|
$ 2,000
|
|
|
|
|
|
Investment cost |
[6],[10],[22],[27] |
|
|
2,012
|
|
|
|
|
|
Investments at Fair Value |
[10],[22],[27] |
|
|
$ 1,934
|
|
|
|
|
|
Investment exit fee |
[10],[12],[22],[27] |
|
|
4.76%
|
|
|
|
4.76%
|
|
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Viridian Therapeutics, Inc. Senior Secured, Maturity Date October 2026, Prime + 4.20%, Floor rate 7.45%, Cap rate 8.95%, 6.00% Exit Fee |
|
|
|
|
|
|
|
|
|
Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[8],[9],[25] |
2026-10
|
|
|
|
2026-10
|
|
|
|
Investment, basis spread, variable rate |
[8],[9],[11],[25] |
4.20%
|
|
|
|
4.20%
|
|
|
|
Investment, interest rate, floor |
[8],[9],[11],[25] |
7.45%
|
|
|
|
7.45%
|
|
|
|
Investment, interest rate, cap |
[8],[9],[11],[25] |
8.95%
|
|
|
|
8.95%
|
|
|
|
Principal amount |
[8],[9],[25] |
$ 8,000
|
|
|
|
|
|
|
|
Investment cost |
[2],[8],[9],[25] |
8,015
|
|
|
|
|
|
|
|
Investments at Fair Value |
[8],[9],[25] |
$ 7,854
|
|
|
|
|
|
|
|
Investment exit fee |
[8],[9],[11],[25] |
6.00%
|
|
|
|
6.00%
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and X4 Pharmaceuticals, Inc. Senior Secured, Maturity Date April 2026, Prime + 3.15%, Floor rate 10.15%, 6.35% Exit Fee |
|
|
|
|
|
|
|
|
|
Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[8],[13],[19] |
2026-10
|
|
|
|
2026-10
|
|
|
|
Investment, basis spread, variable rate |
[8],[11],[13],[19] |
3.15%
|
|
|
|
3.15%
|
|
|
|
Investment, interest rate, floor |
[8],[11],[13],[19] |
10.15%
|
|
|
|
10.15%
|
|
|
|
Principal amount |
[8],[13],[19] |
$ 55,000
|
|
|
|
|
|
|
|
Investment cost |
[2],[8],[13],[19] |
54,444
|
|
|
|
|
|
|
|
Investments at Fair Value |
[8],[13],[19] |
$ 54,762
|
|
|
|
|
|
|
|
Investment exit fee |
[8],[11],[13],[19] |
3.80%
|
|
|
|
3.80%
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and X4 Pharmaceuticals, Inc. Senior Secured, Maturity Date July 2024, Prime + 3.75%, Floor rate 8.75%, 8.80% Exit Fee |
|
|
|
|
|
|
|
|
|
Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[17],[22],[23] |
|
|
2024-07
|
|
|
|
2024-07
|
|
Investment, basis spread, variable rate |
[12],[17],[22],[23] |
|
|
3.75%
|
|
|
|
3.75%
|
|
Investment, interest rate, floor |
[12],[17],[22],[23] |
|
|
8.75%
|
|
|
|
8.75%
|
|
Principal amount |
[17],[22],[23] |
|
|
$ 32,500
|
|
|
|
|
|
Investment cost |
[6],[17],[22],[23] |
|
|
33,705
|
|
|
|
|
|
Investments at Fair Value |
[17],[22],[23] |
|
|
$ 33,700
|
|
|
|
|
|
Investment exit fee |
[12],[17],[22],[23] |
|
|
8.80%
|
|
|
|
8.80%
|
|
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and enGene, Inc. Senior Secured, Maturity Date July 2025, Prime + 5.00%, Floor rate 8.25%, 6.35% Exit Fee |
|
|
|
|
|
|
|
|
|
Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2025-07
|
[8],[13],[25],[26] |
2025-07
|
[22],[23],[27],[28] |
2025-07
|
[8],[13],[25],[26] |
2025-07
|
[22],[23],[27],[28] |
Investment, basis spread, variable rate |
|
5.00%
|
[8],[11],[13],[25],[26] |
5.00%
|
[12],[22],[23],[27],[28] |
5.00%
|
[8],[11],[13],[25],[26] |
5.00%
|
[12],[22],[23],[27],[28] |
Investment, interest rate, floor |
|
8.25%
|
[8],[11],[13],[25],[26] |
8.25%
|
[12],[22],[23],[27],[28] |
8.25%
|
[8],[11],[13],[25],[26] |
8.25%
|
[12],[22],[23],[27],[28] |
Principal amount |
|
$ 9,842
|
[8],[13],[25],[26] |
$ 11,000
|
[22],[23],[27],[28] |
|
|
|
|
Investment cost |
|
10,151
|
[2],[8],[13],[25],[26] |
11,072
|
[6],[22],[23],[27],[28] |
|
|
|
|
Investments at Fair Value |
|
$ 10,222
|
[8],[13],[25],[26] |
$ 11,067
|
[22],[23],[27],[28] |
|
|
|
|
Investment exit fee |
|
6.35%
|
[8],[11],[13],[25],[26] |
6.35%
|
[12],[22],[23],[27],[28] |
6.35%
|
[8],[11],[13],[25],[26] |
6.35%
|
[12],[22],[23],[27],[28] |
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and uniQure B.V. Senior Secured, Maturity Date December 2025, Prime + 4.70%, Floor rate 7.95%, 6.10% Exit Fee |
|
|
|
|
|
|
|
|
|
Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[13],[19],[25],[26] |
2027-01
|
|
|
|
2027-01
|
|
|
|
Investment, basis spread, variable rate |
[11],[13],[19],[25],[26] |
4.70%
|
|
|
|
4.70%
|
|
|
|
Investment, interest rate, floor |
[11],[13],[19],[25],[26] |
7.95%
|
|
|
|
7.95%
|
|
|
|
Principal amount |
[13],[19],[25],[26] |
$ 70,000
|
|
|
|
|
|
|
|
Investment cost |
[2],[13],[19],[25],[26] |
70,915
|
|
|
|
|
|
|
|
Investments at Fair Value |
[13],[19],[25],[26] |
$ 73,203
|
|
|
|
|
|
|
|
Investment exit fee |
[11],[13],[19],[25],[26] |
6.10%
|
|
|
|
6.10%
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and uniQure B.V. Senior Secured, Maturity Date December 2025, Prime + 4.70%, Floor rate 7.95%, 7.28% Exit Fee |
|
|
|
|
|
|
|
|
|
Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[17],[23],[24],[27],[28] |
|
|
2025-12
|
|
|
|
2025-12
|
|
Investment, basis spread, variable rate |
[12],[17],[23],[24],[27],[28] |
|
|
4.70%
|
|
|
|
4.70%
|
|
Investment, interest rate, floor |
[12],[17],[23],[24],[27],[28] |
|
|
7.95%
|
|
|
|
7.95%
|
|
Principal amount |
[17],[23],[24],[27],[28] |
|
|
$ 70,000
|
|
|
|
|
|
Investment cost |
[6],[17],[23],[24],[27],[28] |
|
|
72,329
|
|
|
|
|
|
Investments at Fair Value |
[17],[23],[24],[27],[28] |
|
|
$ 73,019
|
|
|
|
|
|
Investment exit fee |
[12],[17],[23],[24],[27],[28] |
|
|
7.28%
|
|
|
|
7.28%
|
|
Investment, Identifier [Axis]: Debt Investments Electronics & Computer Hardware (1.16%) |
|
|
|
|
|
|
|
|
|
Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
|
Investment owned, percent of net assets |
[4] |
1.16%
|
|
|
|
1.16%
|
|
|
|
Investment cost |
[2] |
$ 18,301
|
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 19,084
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Electronics & Computer Hardware (1.34%) |
|
|
|
|
|
|
|
|
|
Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
|
Investment owned, percent of net assets |
[5] |
|
|
1.34%
|
|
|
|
1.34%
|
|
Investment cost |
[6] |
|
|
$ 18,171
|
|
|
|
|
|
Investments at Fair Value |
|
|
|
$ 18,723
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Electronics & Computer Hardware and Locus Robotics Corp. Senior Secured, Maturity Date June 2026, Prime + 4.50%, Floor rate 8.00%, 1.00% Exit Fee |
|
|
|
|
|
|
|
|
|
Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2026-06
|
[9],[14] |
2026-06
|
[15] |
2026-06
|
[9],[14] |
2026-06
|
[15] |
Investment, basis spread, variable rate |
|
4.50%
|
[9],[11],[14] |
4.50%
|
[12],[15] |
4.50%
|
[9],[11],[14] |
4.50%
|
[12],[15] |
Investment, interest rate, floor |
|
8.00%
|
[9],[11],[14] |
8.00%
|
[12],[15] |
8.00%
|
[9],[11],[14] |
8.00%
|
[12],[15] |
Principal amount |
|
$ 18,281
|
[9],[14] |
$ 18,281
|
[15] |
|
|
|
|
Investment cost |
|
18,301
|
[2],[9],[14] |
18,171
|
[6],[15] |
|
|
|
|
Investments at Fair Value |
|
$ 19,084
|
[9],[14] |
$ 18,723
|
[15] |
|
|
|
|
Investment exit fee |
|
1.00%
|
[9],[11],[14] |
1.00%
|
[12],[15] |
1.00%
|
[9],[11],[14] |
1.00%
|
[12],[15] |
Investment, Identifier [Axis]: Debt Investments Healthcare Services, Other (13.98%) |
|
|
|
|
|
|
|
|
|
Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
|
Investment owned, percent of net assets |
[5] |
|
|
13.98%
|
|
|
|
13.98%
|
|
Investment cost |
[6] |
|
|
$ 196,342
|
|
|
|
|
|
Investments at Fair Value |
|
|
|
$ 195,855
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Healthcare Services, Other (16.72%) |
|
|
|
|
|
|
|
|
|
Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
|
Investment owned, percent of net assets |
[4] |
16.72%
|
|
|
|
16.72%
|
|
|
|
Investment cost |
[2] |
$ 275,632
|
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 276,302
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Healthcare Services, Other and Better Therapeutics, Inc. Senior Secured, Maturity Date August 2025, Prime + 5.70%, Floor rate 8.95%, 5.95% Exit Fee |
|
|
|
|
|
|
|
|
|
Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2025-08
|
[1] |
2025-08
|
[31] |
2025-08
|
[1] |
2025-08
|
[31] |
Investment, basis spread, variable rate |
|
5.70%
|
[1],[11] |
5.70%
|
[12],[31] |
5.70%
|
[1],[11] |
5.70%
|
[12],[31] |
Investment, interest rate, floor |
|
8.95%
|
[1],[11] |
8.95%
|
[12],[31] |
8.95%
|
[1],[11] |
8.95%
|
[12],[31] |
Principal amount |
|
$ 11,314
|
[1] |
$ 12,000
|
[31] |
|
|
|
|
Investment cost |
|
11,671
|
[1],[2] |
12,162
|
[6],[31] |
|
|
|
|
Investments at Fair Value |
|
$ 11,353
|
[1] |
$ 12,053
|
[31] |
|
|
|
|
Investment exit fee |
|
5.95%
|
[1],[11] |
5.95%
|
[12],[31] |
5.95%
|
[1],[11] |
5.95%
|
[12],[31] |
Investment, Identifier [Axis]: Debt Investments Healthcare Services, Other and Blue Sprig Pediatrics, Inc. Senior Secured, Maturity Date November 2026, 1-month LIBOR + 5.00%, Floor rate 6.00%, PIK Interest 4.45% |
|
|
|
|
|
|
|
|
|
Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[16],[17],[22] |
|
|
2026-11
|
|
|
|
2026-11
|
|
Investment, basis spread, variable rate |
[12],[16],[17],[22] |
|
|
5.00%
|
|
|
|
5.00%
|
|
Investment, interest rate, floor |
[12],[16],[17],[22] |
|
|
6.00%
|
|
|
|
6.00%
|
|
Investment, interest rate, paid in kind |
[12],[16],[17],[22] |
|
|
4.45%
|
|
|
|
4.45%
|
|
Principal amount |
[16],[17],[22] |
|
|
$ 51,480
|
|
|
|
|
|
Investment cost |
[6],[16],[17],[22] |
|
|
50,813
|
|
|
|
|
|
Investments at Fair Value |
[16],[17],[22] |
|
|
$ 49,732
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Healthcare Services, Other and Blue Sprig Pediatrics, Inc. Senior Secured, Maturity Date November 2026, 1-month SOFR + 5.11%, Floor rate 6.00%, PIK Interest 4.45% |
|
|
|
|
|
|
|
|
|
Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[7],[8],[19] |
2026-11
|
|
|
|
2026-11
|
|
|
|
Investment, basis spread, variable rate |
[7],[8],[11],[19] |
5.11%
|
|
|
|
5.11%
|
|
|
|
Investment, interest rate, floor |
[7],[8],[11],[19] |
6.00%
|
|
|
|
6.00%
|
|
|
|
Investment, interest rate, paid in kind |
[7],[8],[11],[19] |
4.45%
|
|
|
|
4.45%
|
|
|
|
Principal amount |
[7],[8],[19] |
$ 58,316
|
|
|
|
|
|
|
|
Investment cost |
[2],[7],[8],[19] |
57,667
|
|
|
|
|
|
|
|
Investments at Fair Value |
[7],[8],[19] |
$ 57,926
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Healthcare Services, Other and Carbon Health Technologies, Inc. Senior Secured, Maturity Date March 2025, Prime + 5.60%, Floor rate 8.85%, 4.61% Exit Fee |
|
|
|
|
|
|
|
|
|
Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2025-03
|
[8],[19] |
2025-03
|
[15],[17],[22] |
2025-03
|
[8],[19] |
2025-03
|
[15],[17],[22] |
Investment, basis spread, variable rate |
|
5.60%
|
[8],[11],[19] |
5.60%
|
[12],[15],[17],[22] |
5.60%
|
[8],[11],[19] |
5.60%
|
[12],[15],[17],[22] |
Investment, interest rate, floor |
|
8.85%
|
[8],[11],[19] |
8.85%
|
[12],[15],[17],[22] |
8.85%
|
[8],[11],[19] |
8.85%
|
[12],[15],[17],[22] |
Principal amount |
|
$ 46,125
|
[8],[19] |
$ 46,125
|
[15],[17],[22] |
|
|
|
|
Investment cost |
|
47,023
|
[2],[8],[19] |
46,552
|
[6],[15],[17],[22] |
|
|
|
|
Investments at Fair Value |
|
$ 47,342
|
[8],[19] |
$ 46,548
|
[15],[17],[22] |
|
|
|
|
Investment exit fee |
|
4.61%
|
[8],[11],[19] |
4.61%
|
[12],[15],[17],[22] |
4.61%
|
[8],[11],[19] |
4.61%
|
[12],[15],[17],[22] |
Investment, Identifier [Axis]: Debt Investments Healthcare Services, Other and Equality Health, LLC, Senior Secured, Maturity Date February 2026, Prime + 6.25%, Floor rate 9.50%, PIK Interest 1.55% |
|
|
|
|
|
|
|
|
|
Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2026-02
|
[7],[13],[19] |
2026-02
|
[16],[23] |
2026-02
|
[7],[13],[19] |
2026-02
|
[16],[23] |
Investment, basis spread, variable rate |
|
6.25%
|
[7],[11],[13],[19] |
6.25%
|
[12],[16],[23] |
6.25%
|
[7],[11],[13],[19] |
6.25%
|
[12],[16],[23] |
Investment, interest rate, floor |
|
9.50%
|
[7],[11],[13],[19] |
9.50%
|
[12],[16],[23] |
9.50%
|
[7],[11],[13],[19] |
9.50%
|
[12],[16],[23] |
Investment, interest rate, paid in kind |
|
1.55%
|
[7],[11],[13],[19] |
1.55%
|
[12],[16],[23] |
1.55%
|
[7],[11],[13],[19] |
1.55%
|
[12],[16],[23] |
Principal amount |
|
$ 54,213
|
[7],[13],[19] |
$ 53,587
|
[16],[23] |
|
|
|
|
Investment cost |
|
53,893
|
[2],[7],[13],[19] |
53,164
|
[6],[16],[23] |
|
|
|
|
Investments at Fair Value |
|
$ 54,483
|
[7],[13],[19] |
$ 53,871
|
[16],[23] |
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Healthcare Services, Other and Main Street Rural, Inc. Senior Secured, Maturity Date July 2027, Prime + 1.95%, Floor rate 9.95%, 6.85% Exit Fee |
|
|
|
|
|
|
|
|
|
Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[1],[9] |
2027-07
|
|
|
|
2027-07
|
|
|
|
Investment, basis spread, variable rate |
[1],[9],[11] |
1.95%
|
|
|
|
1.95%
|
|
|
|
Investment, interest rate, floor |
[1],[9],[11] |
9.95%
|
|
|
|
9.95%
|
|
|
|
Principal amount |
[1],[9] |
$ 24,500
|
|
|
|
|
|
|
|
Investment cost |
[1],[2],[9] |
24,350
|
|
|
|
|
|
|
|
Investments at Fair Value |
[1],[9] |
$ 24,350
|
|
|
|
|
|
|
|
Investment exit fee |
[1],[9],[11] |
6.85%
|
|
|
|
6.85%
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Healthcare Services, Other and Modern Life, Inc. Senior Secured, Maturity Date February 2027, Prime + 2.75%, Floor rate 8.75%, 3.00% Exit Fee |
|
|
|
|
|
|
|
|
|
Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[8],[9] |
2027-02
|
|
|
|
2027-02
|
|
|
|
Investment, basis spread, variable rate |
[8],[9],[11] |
2.75%
|
|
|
|
2.75%
|
|
|
|
Investment, interest rate, floor |
[8],[9],[11] |
8.75%
|
|
|
|
8.75%
|
|
|
|
Principal amount |
[8],[9] |
$ 13,000
|
|
|
|
|
|
|
|
Investment cost |
[2],[8],[9] |
12,826
|
|
|
|
|
|
|
|
Investments at Fair Value |
[8],[9] |
$ 12,999
|
|
|
|
|
|
|
|
Investment exit fee |
[8],[9],[11] |
3.00%
|
|
|
|
3.00%
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Healthcare Services, Other and Oak Street Health, Inc. Senior Secured, Maturity Date October 2027, Prime + 2.45%, Floor rate 7.95%, Cap rate 9.45%, PIK Interest 1.00%, 4.95% Exit Fee |
|
|
|
|
|
|
|
|
|
Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[10],[16],[27] |
|
|
2027-10
|
|
|
|
2027-10
|
|
Investment, basis spread, variable rate |
[10],[12],[16],[27] |
|
|
2.45%
|
|
|
|
2.45%
|
|
Investment, interest rate, floor |
[10],[12],[16],[27] |
|
|
7.95%
|
|
|
|
7.95%
|
|
Investment, interest rate, cap |
[10],[12],[16],[27] |
|
|
9.45%
|
|
|
|
9.45%
|
|
Investment, interest rate, paid in kind |
[10],[12],[16],[27] |
|
|
1.00%
|
|
|
|
1.00%
|
|
Principal amount |
[10],[16],[27] |
|
|
$ 33,808
|
|
|
|
|
|
Investment cost |
[6],[10],[16],[27] |
|
|
33,651
|
|
|
|
|
|
Investments at Fair Value |
[10],[16],[27] |
|
|
$ 33,651
|
|
|
|
|
|
Investment exit fee |
[10],[12],[16],[27] |
|
|
4.95%
|
|
|
|
4.95%
|
|
Investment, Identifier [Axis]: Debt Investments Healthcare Services, Other and Recover Together, Inc. Senior Secured, Maturity Date July 2027 Prime + 1.90%, Floor rate 10.15%, 7.50% Exit Fee |
|
|
|
|
|
|
|
|
|
Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2027-07
|
|
|
|
2027-07
|
|
|
|
Investment, basis spread, variable rate |
[11] |
1.90%
|
|
|
|
1.90%
|
|
|
|
Investment, interest rate, floor |
[11] |
10.15%
|
|
|
|
10.15%
|
|
|
|
Principal amount |
|
$ 35,000
|
|
|
|
|
|
|
|
Investment cost |
[2] |
34,495
|
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 34,495
|
|
|
|
|
|
|
|
Investment exit fee |
[11] |
7.50%
|
|
|
|
7.50%
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Healthcare Services, Other and Strive Health Holdings, LLC Senior Secured, Maturity Date September 2027, Prime + 0.70%, Floor rate 9.20%, 5.95% Exit Fee |
|
|
|
|
|
|
|
|
|
Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[1] |
2027-09
|
|
|
|
2027-09
|
|
|
|
Investment, basis spread, variable rate |
[1],[11] |
0.70%
|
|
|
|
0.70%
|
|
|
|
Investment, interest rate, floor |
[1],[11] |
9.20%
|
|
|
|
9.20%
|
|
|
|
Principal amount |
[1] |
$ 12,000
|
|
|
|
|
|
|
|
Investment cost |
[1],[2] |
11,822
|
|
|
|
|
|
|
|
Investments at Fair Value |
[1] |
$ 11,822
|
|
|
|
|
|
|
|
Investment exit fee |
[1],[11] |
5.95%
|
|
|
|
5.95%
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Healthcare Services, Other and Vida Health, Inc. Senior Secured, Maturity Date March 2026, 9.20% + Lower of (Prime - 3.25% or 1.00%), Floor rate 9.20%, Cap rate 10.20%, 4.95% Exit Fee |
|
|
|
|
|
|
|
|
|
Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[19] |
2026-03
|
|
|
|
2026-03
|
|
|
|
Investment, interest rate, floor |
[11],[19] |
9.20%
|
|
|
|
9.20%
|
|
|
|
Investment, interest rate, cap |
[11],[19] |
10.20%
|
|
|
|
10.20%
|
|
|
|
Principal amount |
[19] |
$ 22,000
|
|
|
|
|
|
|
|
Investment cost |
[2],[19] |
21,885
|
|
|
|
|
|
|
|
Investments at Fair Value |
[19] |
$ 21,532
|
|
|
|
|
|
|
|
Investment exit fee |
[11],[19] |
4.95%
|
|
|
|
4.95%
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Healthcare Services, Other and Vida Health, Inc. Senior Secured, Maturity Date March 2026, 9.20% + Lower of (Prime - 3.25% or 1.00%), Floor rate 9.20%, Cap rate 10.20%, 4.95% Exit Fee | Minimum |
|
|
|
|
|
|
|
|
|
Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
|
Investment, basis spread, variable rate |
|
(3.25%)
|
|
|
|
(3.25%)
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Healthcare Services, Other and Vida Health, Inc. Senior Secured, Maturity Date March 2026, 9.20% + Lower of (Prime - 3.25% or 1.00%), Floor rate 9.20%, Cap rate 10.20%, 4.95% Exit Fee | Maximum |
|
|
|
|
|
|
|
|
|
Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
|
Investment, basis spread, variable rate |
[11],[19] |
1.00%
|
|
|
|
1.00%
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Information Services (3.72%) |
|
|
|
|
|
|
|
|
|
Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
|
Investment owned, percent of net assets |
[5] |
|
|
3.72%
|
|
|
|
3.72%
|
|
Investment cost |
[6] |
|
|
$ 52,619
|
|
|
|
|
|
Investments at Fair Value |
|
|
|
$ 52,075
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Information Services (7.03%) |
|
|
|
|
|
|
|
|
|
Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
|
Investment owned, percent of net assets |
[4] |
7.03%
|
|
|
|
7.03%
|
|
|
|
Investment cost |
[2] |
$ 115,617
|
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 116,073
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Information Services and Capella Space Corp. Senior Secured, Maturity Date November 2025, Prime + 5.00%, Floor rate 8.25%, PIK Interest 1.10%, 7.00% Exit Fee |
|
|
|
|
|
|
|
|
|
Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2025-11
|
[1],[7] |
2025-11
|
[15],[16],[31] |
2025-11
|
[1],[7] |
2025-11
|
[15],[16],[31] |
Investment, basis spread, variable rate |
|
5.00%
|
[1],[7],[11] |
5.00%
|
[12],[15],[16],[31] |
5.00%
|
[1],[7],[11] |
5.00%
|
[12],[15],[16],[31] |
Investment, interest rate, floor |
|
8.25%
|
[1],[7],[11] |
8.25%
|
[12],[15],[16],[31] |
8.25%
|
[1],[7],[11] |
8.25%
|
[12],[15],[16],[31] |
Investment, interest rate, paid in kind |
|
1.10%
|
[1],[7],[11] |
1.10%
|
[12],[15],[16],[31] |
1.10%
|
[1],[7],[11] |
1.10%
|
[12],[15],[16],[31] |
Principal amount |
|
$ 20,420
|
[1],[7] |
$ 20,250
|
[15],[16],[31] |
|
|
|
|
Investment cost |
|
20,994
|
[1],[2],[7] |
20,506
|
[6],[15],[16],[31] |
|
|
|
|
Investments at Fair Value |
|
$ 21,154
|
[1],[7] |
$ 20,574
|
[15],[16],[31] |
|
|
|
|
Investment exit fee |
|
7.00%
|
[1],[7],[11] |
7.00%
|
[12],[15],[16],[31] |
7.00%
|
[1],[7],[11] |
7.00%
|
[12],[15],[16],[31] |
Investment, Identifier [Axis]: Debt Investments Information Services and Checkr Group, Inc. Senior Secured, Maturity Date August 2028, Prime + 1.45%, Floor rate 8.00%, PIK Interest 2.00%, 2.75% Exit Fee |
|
|
|
|
|
|
|
|
|
Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[7],[9] |
2028-08
|
|
|
|
2028-08
|
|
|
|
Investment, basis spread, variable rate |
[7],[9],[11] |
1.45%
|
|
|
|
1.45%
|
|
|
|
Investment, interest rate, floor |
[7],[9],[11] |
8.00%
|
|
|
|
8.00%
|
|
|
|
Investment, interest rate, paid in kind |
[7],[9],[11] |
2.00%
|
|
|
|
2.00%
|
|
|
|
Principal amount |
[7],[9] |
$ 47,381
|
|
|
|
|
|
|
|
Investment cost |
[2],[7],[9] |
47,164
|
|
|
|
|
|
|
|
Investments at Fair Value |
[7],[9] |
$ 47,164
|
|
|
|
|
|
|
|
Investment exit fee |
[7],[9],[11] |
2.75%
|
|
|
|
2.75%
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Information Services and Saama Technologies, LLC Senior Secured, Maturity Date July 2027, Prime + 0.70%, Floor rate 8.95%, PIK Interest 2.00%, 2.95% Exit Fee |
|
|
|
|
|
|
|
|
|
Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[7],[9] |
2027-07
|
|
|
|
2027-07
|
|
|
|
Investment, basis spread, variable rate |
[7],[9],[11] |
0.70%
|
|
|
|
0.70%
|
|
|
|
Investment, interest rate, floor |
[7],[9],[11] |
8.95%
|
|
|
|
8.95%
|
|
|
|
Investment, interest rate, paid in kind |
[7],[9],[11] |
2.00%
|
|
|
|
2.00%
|
|
|
|
Principal amount |
[7],[9] |
$ 11,666
|
|
|
|
|
|
|
|
Investment cost |
[2],[7],[9] |
11,544
|
|
|
|
|
|
|
|
Investments at Fair Value |
[7],[9] |
$ 11,544
|
|
|
|
|
|
|
|
Investment exit fee |
[7],[9],[11] |
2.95%
|
|
|
|
2.95%
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Information Services and Signal Media Limited, Senior Secured, Maturity Date June 2025, Prime + 5.50%, Floor rate 9.00%, Cap rate 12.00%, 3.45% Exit Fee |
|
|
|
|
|
|
|
|
|
Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2025-06
|
[9],[25],[26] |
2025-06
|
[10],[27],[28] |
2025-06
|
[9],[25],[26] |
2025-06
|
[10],[27],[28] |
Investment, basis spread, variable rate |
|
5.50%
|
[9],[11],[25],[26] |
5.50%
|
[10],[12],[27],[28] |
5.50%
|
[9],[11],[25],[26] |
5.50%
|
[10],[12],[27],[28] |
Investment, interest rate, floor |
|
9.00%
|
[9],[11],[25],[26] |
9.00%
|
[10],[12],[27],[28] |
9.00%
|
[9],[11],[25],[26] |
9.00%
|
[10],[12],[27],[28] |
Investment, interest rate, cap |
|
12.00%
|
[9],[11],[25],[26] |
12.00%
|
[10],[12],[27],[28] |
12.00%
|
[9],[11],[25],[26] |
12.00%
|
[10],[12],[27],[28] |
Principal amount |
|
$ 4,500
|
[9],[25],[26] |
$ 750
|
[10],[27],[28] |
|
|
|
|
Investment cost |
|
4,463
|
[2],[9],[25],[26] |
742
|
[6],[10],[27],[28] |
|
|
|
|
Investments at Fair Value |
|
$ 4,454
|
[9],[25],[26] |
$ 738
|
[10],[27],[28] |
|
|
|
|
Investment exit fee |
|
3.45%
|
[9],[11],[25],[26] |
3.45%
|
[10],[12],[27],[28] |
3.45%
|
[9],[11],[25],[26] |
3.45%
|
[10],[12],[27],[28] |
Investment, Identifier [Axis]: Debt Investments Information Services and Yipit, LLC, Senior Secured, Maturity Date September 2026, 1-month SOFR + 8.47%, Floor rate 9.37% |
|
|
|
|
|
|
|
|
|
Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[9],[20] |
2026-09
|
|
|
|
2026-09
|
|
|
|
Investment, basis spread, variable rate |
[9],[11],[20] |
8.47%
|
|
|
|
8.47%
|
|
|
|
Investment, interest rate, floor |
[9],[11],[20] |
9.37%
|
|
|
|
9.37%
|
|
|
|
Principal amount |
[9],[20] |
$ 31,875
|
|
|
|
|
|
|
|
Investment cost |
[2],[9],[20] |
31,452
|
|
|
|
|
|
|
|
Investments at Fair Value |
[9],[20] |
$ 31,757
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Information Services and Yipit, LLC, Senior Secured, Maturity Date September 2026, 1-month SOFR + 9.08%, Floor rate 10.08% |
|
|
|
|
|
|
|
|
|
Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[10],[18] |
|
|
2026-09
|
|
|
|
2026-09
|
|
Investment, basis spread, variable rate |
[10],[12],[18] |
|
|
9.08%
|
|
|
|
9.08%
|
|
Investment, interest rate, floor |
[10],[12],[18] |
|
|
10.08%
|
|
|
|
10.08%
|
|
Principal amount |
[10],[18] |
|
|
$ 31,875
|
|
|
|
|
|
Investment cost |
[6],[10],[18] |
|
|
31,371
|
|
|
|
|
|
Investments at Fair Value |
[10],[18] |
|
|
$ 30,763
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Manufacturing Technology (1.44%) |
|
|
|
|
|
|
|
|
|
Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
|
Investment owned, percent of net assets |
[4] |
1.44%
|
|
|
|
1.44%
|
|
|
|
Investment cost |
[2] |
$ 23,069
|
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 23,716
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Manufacturing Technology (2.99%) |
|
|
|
|
|
|
|
|
|
Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
|
Investment owned, percent of net assets |
[5] |
|
|
2.99%
|
|
|
|
2.99%
|
|
Investment cost |
[6] |
|
|
$ 41,568
|
|
|
|
|
|
Investments at Fair Value |
|
|
|
$ 41,953
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Manufacturing Technology and Bright Machines, Inc. Senior Secured, Maturity Date April 2025, Prime + 4.00%, Floor rate 9.50%, 5.00% Exit Fee |
|
|
|
|
|
|
|
|
|
Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2025-04
|
[8] |
2025-04
|
[22] |
2025-04
|
[8] |
2025-04
|
[22] |
Investment, basis spread, variable rate |
|
4.00%
|
[8],[11] |
4.00%
|
[12],[22] |
4.00%
|
[8],[11] |
4.00%
|
[12],[22] |
Investment, interest rate, floor |
|
9.50%
|
[8],[11] |
9.50%
|
[12],[22] |
9.50%
|
[8],[11] |
9.50%
|
[12],[22] |
Principal amount |
|
$ 8,748
|
[8] |
$ 11,050
|
[22] |
|
|
|
|
Investment cost |
|
8,884
|
[2],[8] |
10,832
|
[6],[22] |
|
|
|
|
Investments at Fair Value |
|
$ 8,920
|
[8] |
$ 10,832
|
[22] |
|
|
|
|
Investment exit fee |
|
5.00%
|
[8],[11] |
5.00%
|
[12],[22] |
5.00%
|
[8],[11] |
5.00%
|
[12],[22] |
Investment, Identifier [Axis]: Debt Investments Manufacturing Technology and MacroFab, Inc. Senior Secured, Maturity Date March 2026, Prime + 4.35%, Floor rate 7.60%, PIK Interest 1.25%, 4.50% Exit Fee |
|
|
|
|
|
|
|
|
|
Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[10],[16] |
|
|
2026-03
|
|
|
|
2026-03
|
|
Investment, basis spread, variable rate |
[10],[12],[16] |
|
|
4.35%
|
|
|
|
4.35%
|
|
Investment, interest rate, floor |
[10],[12],[16] |
|
|
7.60%
|
|
|
|
7.60%
|
|
Investment, interest rate, paid in kind |
[10],[12],[16] |
|
|
1.25%
|
|
|
|
1.25%
|
|
Principal amount |
[10],[16] |
|
|
$ 17,137
|
|
|
|
|
|
Investment cost |
[6],[10],[16] |
|
|
16,766
|
|
|
|
|
|
Investments at Fair Value |
[10],[16] |
|
|
$ 16,917
|
|
|
|
|
|
Investment exit fee |
[10],[12],[16] |
|
|
4.50%
|
|
|
|
4.50%
|
|
Investment, Identifier [Axis]: Debt Investments Manufacturing Technology and Ouster, Inc. Senior Secured, Maturity Date May 2026, Prime + 6.15%, Floor rate 9.40%, 7.45% Exit Fee |
|
|
|
|
|
|
|
|
|
Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2026-05
|
[8],[25] |
2026-05
|
[22],[27] |
2026-05
|
[8],[25] |
2026-05
|
[22],[27] |
Investment, basis spread, variable rate |
|
6.15%
|
[8],[11],[25] |
6.15%
|
[12],[22],[27] |
6.15%
|
[8],[11],[25] |
6.15%
|
[12],[22],[27] |
Investment, interest rate, floor |
|
9.40%
|
[8],[11],[25] |
9.40%
|
[12],[22],[27] |
9.40%
|
[8],[11],[25] |
9.40%
|
[12],[22],[27] |
Principal amount |
|
$ 14,000
|
[8],[25] |
$ 14,000
|
[22],[27] |
|
|
|
|
Investment cost |
|
14,185
|
[2],[8],[25] |
13,970
|
[6],[22],[27] |
|
|
|
|
Investments at Fair Value |
|
$ 14,796
|
[8],[25] |
$ 14,204
|
[22],[27] |
|
|
|
|
Investment exit fee |
|
7.45%
|
[8],[11],[25] |
7.45%
|
[12],[22],[27] |
7.45%
|
[8],[11],[25] |
7.45%
|
[12],[22],[27] |
Investment, Identifier [Axis]: Debt Investments Media/Content/Info (0.78%) |
|
|
|
|
|
|
|
|
|
Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
|
Investment owned, percent of net assets |
[4] |
0.78%
|
|
|
|
0.78%
|
|
|
|
Investment cost |
[2] |
$ 12,774
|
|
|
|
|
|
|
|
Investments at Fair Value |
|
12,881
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Media/Content/Info and Fever Labs, Inc. |
|
|
|
|
|
|
|
|
|
Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
|
Principal amount |
|
12,834
|
|
|
|
|
|
|
|
Investment cost |
[2] |
12,774
|
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 12,881
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Media/Content/Info and Fever Labs, Inc. , Maturity Date June 2026, Prime + 3.50%, Floor rate 9.00%, 1.00% Exit Fee |
|
|
|
|
|
|
|
|
|
Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[14] |
2026-06
|
|
|
|
2026-06
|
|
|
|
Investment, basis spread, variable rate |
[11],[14] |
3.50%
|
|
|
|
3.50%
|
|
|
|
Investment, interest rate, floor |
[11],[14] |
9.00%
|
|
|
|
9.00%
|
|
|
|
Principal amount |
[14] |
$ 1,667
|
|
|
|
|
|
|
|
Investment cost |
[2],[14] |
1,635
|
|
|
|
|
|
|
|
Investments at Fair Value |
[14] |
$ 1,638
|
|
|
|
|
|
|
|
Investment exit fee |
[11],[14] |
1.00%
|
|
|
|
1.00%
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Media/Content/Info and Fever Labs, Inc. Senior Secured, Maturity Date December 2025, Prime + 3.50%, Floor rate 9.00%, 1.00% Exit Fee |
|
|
|
|
|
|
|
|
|
Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[14] |
2025-12
|
|
|
|
2025-12
|
|
|
|
Investment, basis spread, variable rate |
[11],[14] |
3.50%
|
|
|
|
3.50%
|
|
|
|
Investment, interest rate, floor |
[11],[14] |
9.00%
|
|
|
|
9.00%
|
|
|
|
Principal amount |
[14] |
$ 1,500
|
|
|
|
|
|
|
|
Investment cost |
[2],[14] |
1,499
|
|
|
|
|
|
|
|
Investments at Fair Value |
[14] |
$ 1,508
|
|
|
|
|
|
|
|
Investment exit fee |
[11],[14] |
1.00%
|
|
|
|
1.00%
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Media/Content/Info and Fever Labs, Inc. Senior Secured, Maturity Date March 2026, Prime + 3.50%, Floor rate 9.00%, 1.00% Exit Fee |
|
|
|
|
|
|
|
|
|
Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[14] |
2026-03
|
|
|
|
2026-03
|
|
|
|
Investment, basis spread, variable rate |
[11],[14] |
3.50%
|
|
|
|
3.50%
|
|
|
|
Investment, interest rate, floor |
[11],[14] |
9.00%
|
|
|
|
9.00%
|
|
|
|
Principal amount |
[14] |
$ 1,667
|
|
|
|
|
|
|
|
Investment cost |
[2],[14] |
1,658
|
|
|
|
|
|
|
|
Investments at Fair Value |
[14] |
$ 1,663
|
|
|
|
|
|
|
|
Investment exit fee |
[11],[14] |
1.00%
|
|
|
|
1.00%
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Media/Content/Info and Fever Labs, Inc. Senior Secured, Maturity Date September 2025, Prime + 3.50%, Floor rate 9.00%, 1.00% Exit Fee |
|
|
|
|
|
|
|
|
|
Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[14] |
2025-09
|
|
|
|
2025-09
|
|
|
|
Investment, basis spread, variable rate |
[11],[14] |
3.50%
|
|
|
|
3.50%
|
|
|
|
Investment, interest rate, floor |
[11],[14] |
9.00%
|
|
|
|
9.00%
|
|
|
|
Principal amount |
[14] |
$ 1,333
|
|
|
|
|
|
|
|
Investment cost |
[2],[14] |
1,337
|
|
|
|
|
|
|
|
Investments at Fair Value |
[14] |
$ 1,346
|
|
|
|
|
|
|
|
Investment exit fee |
[11],[14] |
1.00%
|
|
|
|
1.00%
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Media/Content/Info and Fever Labs, Inc. Senior Secured, Maturity Date September 2026, Prime + 3.50%, Floor rate 9.00%, 1.00% Exit Fee |
|
|
|
|
|
|
|
|
|
Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[14] |
2026-09
|
|
|
|
2026-09
|
|
|
|
Investment, basis spread, variable rate |
[11],[14] |
3.50%
|
|
|
|
3.50%
|
|
|
|
Investment, interest rate, floor |
[11],[14] |
9.00%
|
|
|
|
9.00%
|
|
|
|
Principal amount |
[14] |
$ 6,667
|
|
|
|
|
|
|
|
Investment cost |
[2],[14] |
6,645
|
|
|
|
|
|
|
|
Investments at Fair Value |
[14] |
$ 6,726
|
|
|
|
|
|
|
|
Investment exit fee |
[11],[14] |
1.00%
|
|
|
|
1.00%
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Medical Devices & Equipment (1.30%) |
|
|
|
|
|
|
|
|
|
Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
|
Investment owned, percent of net assets |
[4] |
1.30%
|
|
|
|
1.30%
|
|
|
|
Investment cost |
[2] |
$ 21,461
|
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 21,461
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Medical Devices & Equipment and Senseonics Holdings, Inc. Prime + 1.40%, Floor rate 9.90%, 6.95% Exit Fee |
|
|
|
|
|
|
|
|
|
Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2027-09
|
|
|
|
2027-09
|
|
|
|
Investment, basis spread, variable rate |
[11] |
1.40%
|
|
|
|
1.40%
|
|
|
|
Investment, interest rate, floor |
[11] |
9.90%
|
|
|
|
9.90%
|
|
|
|
Principal amount |
|
$ 21,875
|
|
|
|
|
|
|
|
Investment cost |
[2] |
21,461
|
|
|
|
|
|
|
|
Investments at Fair Value |
|
$ 21,461
|
|
|
|
|
|
|
|
Investment exit fee |
[11] |
6.95%
|
|
|
|
6.95%
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Semiconductors (1.51%) |
|
|
|
|
|
|
|
|
|
Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
|
Investment owned, percent of net assets |
[5] |
|
|
1.51%
|
|
|
|
1.51%
|
|
Investment cost |
[6] |
|
|
$ 19,639
|
|
|
|
|
|
Investments at Fair Value |
|
|
|
$ 21,192
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Semiconductors and Fungible, Inc. Senior Secured, Maturity Date December 2024, Prime + 5.00%, Floor rate 8.25%, 4.95% Exit Fee |
|
|
|
|
|
|
|
|
|
Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[15],[31] |
|
|
2024-12
|
|
|
|
2024-12
|
|
Investment, basis spread, variable rate |
[12],[15],[31] |
|
|
5.00%
|
|
|
|
5.00%
|
|
Investment, interest rate, floor |
[12],[15],[31] |
|
|
8.25%
|
|
|
|
8.25%
|
|
Principal amount |
[15],[31] |
|
|
$ 20,000
|
|
|
|
|
|
Investment cost |
[6],[15],[31] |
|
|
19,639
|
|
|
|
|
|
Investments at Fair Value |
[15],[31] |
|
|
$ 21,192
|
|
|
|
|
|
Investment exit fee |
[12],[15],[31] |
|
|
4.95%
|
|
|
|
4.95%
|
|
Investment, Identifier [Axis]: Debt Investments Software (47.79%) |
|
|
|
|
|
|
|
|
|
Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
|
Investment owned, percent of net assets |
[4] |
47.79%
|
|
|
|
47.79%
|
|
|
|
Investment cost |
[2] |
$ 831,129
|
|
|
|
|
|
|
|
Investments at Fair Value |
|
789,586
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Software (54.28%) |
|
|
|
|
|
|
|
|
|
Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
|
Investment owned, percent of net assets |
[5] |
|
|
54.28%
|
|
|
|
54.28%
|
|
Investment cost |
[6] |
|
|
$ 762,371
|
|
|
|
|
|
Investments at Fair Value |
|
|
|
760,679
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Software and 3GTMS, LLC |
|
|
|
|
|
|
|
|
|
Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
|
Principal amount |
|
14,605
|
|
13,176
|
|
|
|
|
|
Investment cost |
|
14,506
|
[2] |
13,035
|
[6] |
|
|
|
|
Investments at Fair Value |
|
$ 14,532
|
|
$ 12,998
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Software and 3GTMS, LLC, Senior Secured, Maturity Date February 2025, 3-month LIBOR + 6.57%, Floor rate 7.57% |
|
|
|
|
|
|
|
|
|
Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[18] |
|
|
2025-02
|
|
|
|
2025-02
|
|
Investment, basis spread, variable rate |
[12],[18] |
|
|
6.57%
|
|
|
|
6.57%
|
|
Investment, interest rate, floor |
[12],[18] |
|
|
7.57%
|
|
|
|
7.57%
|
|
Principal amount |
[18] |
|
|
$ 2,750
|
|
|
|
|
|
Investment cost |
[6],[18] |
|
|
2,744
|
|
|
|
|
|
Investments at Fair Value |
[18] |
|
|
$ 2,681
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Software and 3GTMS, LLC, Senior Secured, Maturity Date February 2025, 3-month LIBOR + 9.28%, Floor rate 10.28% |
|
|
|
|
|
|
|
|
|
Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[17],[18] |
|
|
2025-02
|
|
|
|
2025-02
|
|
Investment, basis spread, variable rate |
[12],[17],[18] |
|
|
9.28%
|
|
|
|
9.28%
|
|
Investment, interest rate, floor |
[12],[17],[18] |
|
|
10.28%
|
|
|
|
10.28%
|
|
Principal amount |
[17],[18] |
|
|
$ 10,426
|
|
|
|
|
|
Investment cost |
[6],[17],[18] |
|
|
10,291
|
|
|
|
|
|
Investments at Fair Value |
[17],[18] |
|
|
$ 10,317
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Software and 3GTMS, LLC, Senior Secured, Maturity Date February 2025, 3-month SOFR + 6.88%, Floor rate 7.78% |
|
|
|
|
|
|
|
|
|
Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[9],[20] |
2025-02
|
|
|
|
2025-02
|
|
|
|
Investment, basis spread, variable rate |
[9],[11],[20] |
6.88%
|
|
|
|
6.88%
|
|
|
|
Investment, interest rate, floor |
[9],[11],[20] |
7.78%
|
|
|
|
7.78%
|
|
|
|
Principal amount |
[9],[20] |
$ 2,000
|
|
|
|
|
|
|
|
Investment cost |
[2],[9],[20] |
1,998
|
|
|
|
|
|
|
|
Investments at Fair Value |
[9],[20] |
$ 1,984
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Software and 3GTMS, LLC, Senior Secured, Maturity Date February 2025, 6-month SOFR + 9.70%, Floor rate 10.60% |
|
|
|
|
|
|
|
|
|
Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[9],[19],[20] |
2025-02
|
|
|
|
2025-02
|
|
|
|
Investment, basis spread, variable rate |
[9],[11],[19],[20] |
9.70%
|
|
|
|
9.70%
|
|
|
|
Investment, interest rate, floor |
[9],[11],[19],[20] |
10.60%
|
|
|
|
10.60%
|
|
|
|
Principal amount |
[9],[19],[20] |
$ 12,605
|
|
|
|
|
|
|
|
Investment cost |
[2],[9],[19],[20] |
12,508
|
|
|
|
|
|
|
|
Investments at Fair Value |
[9],[19],[20] |
$ 12,548
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Software and Agilence, Inc. Senior Secured, Maturity Date October 2026, 1-month BSBY + 9.00%, Floor rate 10.00% |
|
|
|
|
|
|
|
|
|
Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2026-10
|
[9],[13],[20] |
2026-10
|
[10],[18],[23] |
2026-10
|
[9],[13],[20] |
2026-10
|
[10],[18],[23] |
Investment, basis spread, variable rate |
|
9.00%
|
[9],[11],[13],[20] |
9.00%
|
[10],[12],[18],[23] |
9.00%
|
[9],[11],[13],[20] |
9.00%
|
[10],[12],[18],[23] |
Investment, interest rate, floor |
|
10.00%
|
[9],[11],[13],[20] |
10.00%
|
[10],[12],[18],[23] |
10.00%
|
[9],[11],[13],[20] |
10.00%
|
[10],[12],[18],[23] |
Principal amount |
|
$ 9,236
|
[9],[13],[20] |
$ 9,306
|
[10],[18],[23] |
|
|
|
|
Investment cost |
|
9,051
|
[2],[9],[13],[20] |
9,088
|
[6],[10],[18],[23] |
|
|
|
|
Investments at Fair Value |
|
$ 9,170
|
[9],[13],[20] |
$ 8,977
|
[10],[18],[23] |
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Software and Alchemer LLC, Senior Secured, Maturity Date May 2028, 1-month SOFR + 7.89%, Floor rate 8.89% |
|
|
|
|
|
|
|
|
|
Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[10],[18] |
|
|
2028-05
|
|
|
|
2028-05
|
|
Investment, basis spread, variable rate |
[10],[12],[18] |
|
|
7.89%
|
|
|
|
7.89%
|
|
Investment, interest rate, floor |
[10],[12],[18] |
|
|
8.89%
|
|
|
|
8.89%
|
|
Principal amount |
[10],[18] |
|
|
$ 20,463
|
|
|
|
|
|
Investment cost |
[6],[10],[18] |
|
|
19,999
|
|
|
|
|
|
Investments at Fair Value |
[10],[18] |
|
|
$ 20,123
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Software and Alchemer LLC, Senior Secured, Maturity Date May 2028, 1-month SOFR + 8.14%, Floor rate 9.14% |
|
|
|
|
|
|
|
|
|
Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[8],[9],[20] |
2028-05
|
|
|
|
2028-05
|
|
|
|
Investment, basis spread, variable rate |
[8],[9],[11],[20] |
8.14%
|
|
|
|
8.14%
|
|
|
|
Investment, interest rate, floor |
[8],[9],[11],[20] |
9.14%
|
|
|
|
9.14%
|
|
|
|
Principal amount |
[8],[9],[20] |
$ 20,908
|
|
|
|
|
|
|
|
Investment cost |
[2],[8],[9],[20] |
20,491
|
|
|
|
|
|
|
|
Investments at Fair Value |
[8],[9],[20] |
$ 21,126
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Software and Allvue Systems, LLC, Senior Secured, Maturity Date September 2029, 6-month SOFR + 7.25%, Floor rate 8.25% |
|
|
|
|
|
|
|
|
|
Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[9] |
2029-09
|
|
|
|
2029-09
|
|
|
|
Investment, basis spread, variable rate |
[9],[11] |
7.25%
|
|
|
|
7.25%
|
|
|
|
Investment, interest rate, floor |
[9],[11] |
8.25%
|
|
|
|
8.25%
|
|
|
|
Principal amount |
[9] |
$ 36,410
|
|
|
|
|
|
|
|
Investment cost |
[2],[9] |
35,505
|
|
|
|
|
|
|
|
Investments at Fair Value |
[9] |
$ 35,505
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Software and Annex Cloud, Senior Secured, Maturity Date February 2027, 1-month BSBY + 8.99%, Floor rate 10.00% |
|
|
|
|
|
|
|
|
|
Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[10],[22] |
|
|
2027-02
|
|
|
|
2027-02
|
|
Investment, basis spread, variable rate |
[10],[12],[22] |
|
|
8.99%
|
|
|
|
8.99%
|
|
Investment, interest rate, floor |
[10],[12],[22] |
|
|
10.00%
|
|
|
|
10.00%
|
|
Principal amount |
[10],[22] |
|
|
$ 8,500
|
|
|
|
|
|
Investment cost |
[6],[10],[22] |
|
|
8,292
|
|
|
|
|
|
Investments at Fair Value |
[10],[22] |
|
|
$ 8,176
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Software and Annex Cloud, Senior Secured, Maturity Date February 2027, 1-month BSBY + 8.99%, Floor rate 9.99% |
|
|
|
|
|
|
|
|
|
Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[8] |
2027-02
|
|
|
|
2027-02
|
|
|
|
Investment, basis spread, variable rate |
[8],[11] |
8.99%
|
|
|
|
8.99%
|
|
|
|
Investment, interest rate, floor |
[8],[11] |
9.99%
|
|
|
|
9.99%
|
|
|
|
Principal amount |
[8] |
$ 8,844
|
|
|
|
|
|
|
|
Investment cost |
[2],[8] |
8,666
|
|
|
|
|
|
|
|
Investments at Fair Value |
[8] |
$ 8,737
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Software and Automation Anywhere, Inc. Senior Secured, Maturity Date September 2027, Prime + 4.25%, Floor rate 9.00%, 2.50% Exit Fee |
|
|
|
|
|
|
|
|
|
Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[10],[15],[17] |
|
|
2027-09
|
|
|
|
2027-09
|
|
Investment, basis spread, variable rate |
[10],[12],[15],[17] |
|
|
4.25%
|
|
|
|
4.25%
|
|
Investment, interest rate, floor |
[10],[12],[15],[17] |
|
|
9.00%
|
|
|
|
9.00%
|
|
Principal amount |
[10],[15],[17] |
|
|
$ 19,600
|
|
|
|
|
|
Investment cost |
[6],[10],[15],[17] |
|
|
19,059
|
|
|
|
|
|
Investments at Fair Value |
[10],[15],[17] |
|
|
$ 19,059
|
|
|
|
|
|
Investment exit fee |
[10],[12],[15],[17] |
|
|
2.50%
|
|
|
|
2.50%
|
|
Investment, Identifier [Axis]: Debt Investments Software and Automation Anywhere, Inc. Senior Secured, Maturity Date September 2027, Prime + 4.25%, Floor rate 9.00%, 3.50% Exit Fee |
|
|
|
|
|
|
|
|
|
Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[9],[14],[19] |
2027-09
|
|
|
|
2027-09
|
|
|
|
Investment, basis spread, variable rate |
[9],[11],[14],[19] |
4.25%
|
|
|
|
4.25%
|
|
|
|
Investment, interest rate, floor |
[9],[11],[14],[19] |
9.00%
|
|
|
|
9.00%
|
|
|
|
Principal amount |
[9],[14],[19] |
$ 19,600
|
|
|
|
|
|
|
|
Investment cost |
[2],[9],[14],[19] |
19,270
|
|
|
|
|
|
|
|
Investments at Fair Value |
[9],[14],[19] |
$ 20,032
|
|
|
|
|
|
|
|
Investment exit fee |
[9],[11],[14],[19] |
3.50%
|
|
|
|
3.50%
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Software and Babel Street, Senior Secured, Maturity Date December 2027, 3-month SOFR + 7.89%, Floor rate 8.89% |
|
|
|
|
|
|
|
|
|
Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2027-12
|
[1],[9],[20] |
2027-12
|
[10],[18],[31] |
2027-12
|
[1],[9],[20] |
2027-12
|
[10],[18],[31] |
Investment, basis spread, variable rate |
|
7.89%
|
[1],[9],[11],[20] |
7.89%
|
[10],[12],[18],[31] |
7.89%
|
[1],[9],[11],[20] |
7.89%
|
[10],[12],[18],[31] |
Investment, interest rate, floor |
|
8.89%
|
[1],[9],[11],[20] |
8.89%
|
[10],[12],[18],[31] |
8.89%
|
[1],[9],[11],[20] |
8.89%
|
[10],[12],[18],[31] |
Principal amount |
|
$ 45,000
|
[1],[9],[20] |
$ 45,000
|
[10],[18],[31] |
|
|
|
|
Investment cost |
|
43,935
|
[1],[2],[9],[20] |
43,801
|
[6],[10],[18],[31] |
|
|
|
|
Investments at Fair Value |
|
$ 44,887
|
[1],[9],[20] |
$ 43,801
|
[10],[18],[31] |
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Software and Brain Corporation, Senior Secured, Maturity Date April 2025, PRIME + 3.70%, Floor rate 6.95%, PIK Interest 1.00%, 3.95% Exit Fee |
|
|
|
|
|
|
|
|
|
Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[10],[16],[22],[31] |
|
|
2025-04
|
|
|
|
2025-04
|
|
Investment, basis spread, variable rate |
[10],[12],[16],[22],[31] |
|
|
3.70%
|
|
|
|
3.70%
|
|
Investment, interest rate, floor |
[10],[12],[16],[22],[31] |
|
|
6.95%
|
|
|
|
6.95%
|
|
Investment, interest rate, paid in kind |
[10],[12],[16],[22],[31] |
|
|
1.00%
|
|
|
|
1.00%
|
|
Principal amount |
[10],[16],[22],[31] |
|
|
$ 20,166
|
|
|
|
|
|
Investment cost |
[6],[10],[16],[22],[31] |
|
|
20,242
|
|
|
|
|
|
Investments at Fair Value |
[10],[16],[22],[31] |
|
|
$ 20,138
|
|
|
|
|
|
Investment exit fee |
[10],[12],[16],[22],[31] |
|
|
3.95%
|
|
|
|
3.95%
|
|
Investment, Identifier [Axis]: Debt Investments Software and Brain Corporation, Senior Secured, Maturity Date April 2026, PRIME + 3.70%, Floor rate 9.20%, PIK Interest 1.00%, 3.95% Exit Fee |
|
|
|
|
|
|
|
|
|
Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[1],[7],[8],[9] |
2026-04
|
|
|
|
2026-04
|
|
|
|
Investment, basis spread, variable rate |
[1],[7],[8],[9],[11] |
3.70%
|
|
|
|
3.70%
|
|
|
|
Investment, interest rate, floor |
[1],[7],[8],[9],[11] |
9.20%
|
|
|
|
9.20%
|
|
|
|
Investment, interest rate, paid in kind |
[1],[7],[8],[9],[11] |
1.00%
|
|
|
|
1.00%
|
|
|
|
Principal amount |
[1],[7],[8],[9] |
$ 30,338
|
|
|
|
|
|
|
|
Investment cost |
[1],[2],[7],[8],[9] |
30,490
|
|
|
|
|
|
|
|
Investments at Fair Value |
[1],[7],[8],[9] |
$ 30,694
|
|
|
|
|
|
|
|
Investment exit fee |
[1],[7],[8],[9],[11] |
3.95%
|
|
|
|
3.95%
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Software and Campaign Monitor Limited, Senior Secured, Maturity Date November 2025, 3-month SOFR + 9.05%, Floor rate 9.90% |
|
|
|
|
|
|
|
|
|
Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[8],[14] |
2025-11
|
|
|
|
2025-11
|
|
|
|
Investment, basis spread, variable rate |
[8],[11],[14] |
9.05%
|
|
|
|
9.05%
|
|
|
|
Investment, interest rate, floor |
[8],[11],[14] |
9.90%
|
|
|
|
9.90%
|
|
|
|
Principal amount |
[8],[14] |
$ 33,000
|
|
|
|
|
|
|
|
Investment cost |
[2],[8],[14] |
32,672
|
|
|
|
|
|
|
|
Investments at Fair Value |
[8],[14] |
$ 33,000
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Software and Campaign Monitor Limited, Senior Secured, Maturity Date November 2025, 6-month SOFR + 8.90%, Floor rate 9.90% |
|
|
|
|
|
|
|
|
|
Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[15],[22] |
|
|
2025-11
|
|
|
|
2025-11
|
|
Investment, basis spread, variable rate |
[12],[15],[22] |
|
|
8.90%
|
|
|
|
8.90%
|
|
Investment, interest rate, floor |
[12],[15],[22] |
|
|
9.90%
|
|
|
|
9.90%
|
|
Principal amount |
[15],[22] |
|
|
$ 33,000
|
|
|
|
|
|
Investment cost |
[6],[15],[22] |
|
|
32,578
|
|
|
|
|
|
Investments at Fair Value |
[15],[22] |
|
|
$ 33,000
|
|
|
|
|
|